<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02531802</url>
  </required_header>
  <id_info>
    <org_study_id>VAC 014</org_study_id>
    <nct_id>NCT02531802</nct_id>
  </id_info>
  <brief_title>Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh</brief_title>
  <acronym>ETVAX/dmLT</acronym>
  <official_title>A Randomized, Double-blind, Placebo-controlled, Dose-Escalation Study Evaluating the Safety, Tolerability, and Immunogenicity of an Oral Inactivated ETEC Vaccine (ETVAX) Alone and Together With dmLT Adjuvant in Descending Age Groups in Bangladesh</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PATH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Scandinavian Biopharma AB</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>International Centre for Diarrhoeal Disease Research, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>PATH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the ETEC vaccine ETVAX with and without dmLT
      adjuvant is safe and immunogenic in adults, children, toddlers and infants in Bangladesh.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This Phase I/II trial will serve to assess whether ETVAX is safe and provides mucosal as well
      as systemic immune responses against the key protective antigens when tested in different
      age-groups in Bangladesh. This study provides an opportunity to test the safety profile of a
      mucosal adjuvant, double-mutant LT (dmLT), in adults and children, as well as provide the
      opportunity to potentially assess the ability of dmLT to further enhance the mucosal and
      systemic antibody responses to key antigens in the ETVAX vaccine among age groups in
      developing country sites, like Bangladesh, that have proved refractory to oral immunization
      with enteric vaccines. In addition, this study also allows for the evaluation of the
      potential dose-sparing effect of dmLT when combined with a lower dose of vaccine. Finally,
      this clinical trial is considered an essential study along the critical path of the overall
      clinical development plan before determining whether the vaccine can be tested for protective
      efficacy in children in developing countries.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">July 29, 2017</completion_date>
  <primary_completion_date type="Actual">July 29, 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number and Percentage of Participants Experiencing Solicited Events by Symptom and Maximum Severity</measure>
    <time_frame>7 days after each vaccination (Day 7 and Day 21)</time_frame>
    <description>Adverse events (AEs) were assessed post-vaccination using participant/parent/guardian interview (including memory aids), targeted physical examinations, vital signs and clinical laboratory tests and reactogenicity assessments which were completed following each vaccination. The solicited AEs of nausea (adults only), abdominal pain/stomach ache (adults and children 24-59 months only), fever, vomiting and diarrhea were evaluated daily for 7 days post vaccination.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number and Percentage of Participants Experiencing Unsolicited Adverse Events Related to Vaccine</measure>
    <time_frame>6 months ± 14 days after the first dose</time_frame>
    <description>Adverse events (AEs) were assessed post-vaccination using participant/parent/guardian interview (including memory aids), targeted physical examinations, vital signs and clinical laboratory tests and reactogenicity assessments which were completed following each vaccination. Unsolicited AEs were assessed through Day 42 and serious adverse events (SAEs) were assessed over the entire duration of the study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of Subjects With ≥Two-fold Increase in Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Response After Either Vaccine Dose, by Antigen</measure>
    <time_frame>19 days</time_frame>
    <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of Subjects With ≥Four-fold Increase in Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Response After Either Vaccine Dose, by Antigen</measure>
    <time_frame>19 days</time_frame>
    <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Titer (GMT) of Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Response After Either Vaccine Dose, by Antigen</measure>
    <time_frame>19 days</time_frame>
    <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Fold Change of Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Response After Either Vaccine Dose, by Antigen</measure>
    <time_frame>19 days</time_frame>
    <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of 6-11 Month Old Subjects With ≥Two-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response, by Antigen</measure>
    <time_frame>28 days</time_frame>
    <description>Fecal secretion was measured on Day 7, Day 19, and Day 28; number in table is subjects experiencing a two-fold rise at any of these time points. Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of 6-11 Month Old Subjects With ≥Four-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response, by Antigen</measure>
    <time_frame>28 days</time_frame>
    <description>Fecal secretion was measured on Day 7, Day 19, and Day 28; number in table is subjects experiencing a four-fold rise at any of these time points. Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Titer (GMT) of Fecal Secretory Immunoglobulin A (SIgA) Response 6-11 Month Old Subjects, by Antigen</measure>
    <time_frame>28 days</time_frame>
    <description>Fecal secretion was measured on Day 7, Day 19, and Day 28; number in table is based on the maximum value for each subject. Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Fold Change of Fecal Secretory Immunoglobulin A (SIgA) Response Among 6-11 Month Old Subjects, by Antigen</measure>
    <time_frame>28 days</time_frame>
    <description>Fecal secretion was measured on Day 7, Day 19, and Day 28; number in table is based on the maximum value for each subject. Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of Subjects With ≥Two-fold Increase in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for Antigens in ETVAX</measure>
    <time_frame>19 days</time_frame>
    <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of Subjects With ≥Four-fold Increase in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for Antigens in ETVAX</measure>
    <time_frame>19 days</time_frame>
    <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Titer (GMT) of Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for Antigens in ETVAX</measure>
    <time_frame>19 days</time_frame>
    <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Fold Change in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for Antigens in ETVAX</measure>
    <time_frame>19 days</time_frame>
    <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of Adult Subjects With ≥Two-fold and ≥Four-fold Increase in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for O78 Antigen</measure>
    <time_frame>19 days</time_frame>
    <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Titer (GMT) for Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for O78 Antigen, Among Adults</measure>
    <time_frame>19 days</time_frame>
    <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Fold Change in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for O78 Antigen, Among Adults</measure>
    <time_frame>19 days</time_frame>
    <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of Subjects With ≥Two-fold and ≥Four-fold Increase in Plasma Immunoglobulin G (IgG) Response to E. Coli Heat-labile Enterotoxin (LTB) After Either Vaccine Dose</measure>
    <time_frame>19 days</time_frame>
    <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). B-subunit of the E. coli heat-labile enterotoxin (LTB) was one of the antigens in the ETVAX vaccine.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Titer (GMT) of Plasma Immunoglobulin G (IgG) Response to E. Coli Heat-labile Enterotoxin (LTB) After Either Vaccine Dose</measure>
    <time_frame>19 days</time_frame>
    <description>Measured 7 days after the first dose and 5 days after the second). B-subunit of the E. coli heat-labile enterotoxin (LTB) was one of the antigens in the ETVAX vaccine.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Fold Change of Plasma Immunoglobulin G (IgG) Response to E. Coli Heat-labile Enterotoxin (LTB) After Either Vaccine Dose</measure>
    <time_frame>19 days</time_frame>
    <description>Between baseline and after vaccination (measured 7 days after the first dose and 5 days after the second). B-subunit of the E. coli heat-labile enterotoxin (LTB) was one of the antigens in the ETVAX vaccine.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Antigen Responses in Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Experienced by Subjects</measure>
    <time_frame>19 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Antigen Responses in Plasma Immunoglobulin A (IgA) Experienced by Subjects</measure>
    <time_frame>19 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of 6-11 Month Old Subjects With ≥Two-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 7, by Antigen</measure>
    <time_frame>7 days</time_frame>
    <description>Fecal secretion was measured on Day 0 and Day 7 (7 days after administration of first dose of vaccine). Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of 6-11 Month Old Subjects With ≥Four-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 7, by Antigen</measure>
    <time_frame>7 days</time_frame>
    <description>Fecal secretion was measured on Day 0 and Day 7 (7 days after administration of first dose of vaccine). Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Titer (GMT) of Fecal Secretory Immunoglobulin A (SIgA) Response 6-11 Month Old Subjects on Day 7, by Antigen</measure>
    <time_frame>7 days</time_frame>
    <description>Fecal secretion was measured on Day 7 (7 days after administration of first dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Fold Change of Fecal Secretory Immunoglobulin A (SIgA) Response Among 6-11 Month Old Subjects on Day 7, by Antigen</measure>
    <time_frame>7 days</time_frame>
    <description>Fecal secretion was measured on Day 0 and Day 7 (7 days after administration of first dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of 6-11 Month Old Subjects With ≥Two-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 19, by Antigen</measure>
    <time_frame>Day 19</time_frame>
    <description>Fecal secretion was measured on Day 0 and Day 19 (5 days after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of 6-11 Month Old Subjects With ≥Four-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 19, by Antigen</measure>
    <time_frame>19 days</time_frame>
    <description>Fecal secretion was measured on Day 0 and Day 19 (5 days after administration of second dose of vaccine). Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Titer (GMT) of Fecal Secretory Immunoglobulin A (SIgA) Response 6-11 Month Old Subjects on Day 19, by Antigen</measure>
    <time_frame>19 days</time_frame>
    <description>Fecal secretion was measured on Day 19 (5 days after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Fold Change of Fecal Secretory Immunoglobulin A (SIgA) Response Among 6-11 Month Old Subjects on Day 19, by Antigen</measure>
    <time_frame>19 days</time_frame>
    <description>Fecal secretion was measured on Day 0 and Day 19 (5 days after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of 6-11 Month Old Subjects With ≥Two-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 28, by Antigen</measure>
    <time_frame>28 days</time_frame>
    <description>Fecal secretion was measured on Day 0 and Day 28 (2 weeks after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of 6-11 Month Old Subjects With ≥Four-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 28, by Antigen</measure>
    <time_frame>28 days</time_frame>
    <description>Fecal secretion was measured on Day 0 and Day 28 (2 weeks after administration of second dose of vaccine). Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Titer (GMT) of Fecal Secretory Immunoglobulin A (SIgA) Response 6-11 Month Old Subjects on Day 28, by Antigen</measure>
    <time_frame>28 days</time_frame>
    <description>Fecal secretion was measured on Day 28 (2 weeks after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Fold Change of Fecal Secretory Immunoglobulin A (SIgA) Response Among 6-11 Month Old Subjects on Day 28, by Antigen</measure>
    <time_frame>28 days</time_frame>
    <description>Fecal secretion was measured on Day 0 and Day 28 (2 weeks after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
  </secondary_outcome>
  <number_of_arms>21</number_of_arms>
  <enrollment type="Actual">475</enrollment>
  <condition>Escherichia Coli Diarrhea</condition>
  <arm_group>
    <arm_group_label>Adult: ETVAX (Full)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adult: ETVAX (Full) + 10 ug dmLT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adult: Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>24-59 months: ETVAX (1/4)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>24-59 months: ETVAX (1/2)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>24-59 months: ETVAX (full)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24-59 month old children receiving a full adult dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>24-59 months: ETVAX (1/2) + 2.5 ug dmLT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>24-59 months: ETVAX (1/2) + 5 ug dmLT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>24-59 months: ETVAX (1/2) + 10 ug dmLT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>24-59 months: Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12-23 months: ETVAX (1/4)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12-23 months: ETVAX (1/2)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12-23 months: ETVAX (1/2) + 2.5 ug dmLT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12-23 months: ETVAX (1/2) + 5 ug dmLT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12-23 months: Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6-11 months: ETVAX (1/8)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6-11 months: ETVAX (1/4)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6-11 months: ETVAX (1/2)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6-11 months: ETVAX (1/4) + 2.5 ug dmLT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6-11 month olds: ETVAX (1/4) + 5 ug dmLT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6-11 month olds: Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>ETVAX</intervention_name>
    <description>Varying dosages of liquid ETVAX vaccine (Batch BX1003574). A full dose consisted of:
Hybrid protein between the B-subunit of the E. coli heat-labile enterotoxin and the B-subunit of the cholera toxin (LCTBA): 1 mg
E. coli ETEX 21 formalin inactivated: 1.3 mg colonization factor 1 (CFA/I)
E. coli ETEX 22 formalin inactivated: 6.4 mg coli surface antigen 3 (CS3)
E. coli ETEX 23 formalin inactivated: 1.1 mg coli surface antigen 5 (CS5)
E. coli ETEX 24 phenol inactivated: 0.5 mg coli surface antigen 6 (CS6)
The vaccine was given together with sodium bicarbonate effervescent granules (Recip), which was dissolved in water and mixed with the vaccine suspension prior to oral administration. The buffer was used to prevent degradation of LCTBA hybrid protein by the gastric acid.</description>
    <arm_group_label>12-23 months: ETVAX (1/2)</arm_group_label>
    <arm_group_label>12-23 months: ETVAX (1/2) + 2.5 ug dmLT</arm_group_label>
    <arm_group_label>12-23 months: ETVAX (1/2) + 5 ug dmLT</arm_group_label>
    <arm_group_label>12-23 months: ETVAX (1/4)</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (1/2)</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (1/2) + 10 ug dmLT</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (1/2) + 2.5 ug dmLT</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (1/2) + 5 ug dmLT</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (1/4)</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (full)</arm_group_label>
    <arm_group_label>6-11 month olds: ETVAX (1/4) + 5 ug dmLT</arm_group_label>
    <arm_group_label>6-11 months: ETVAX (1/2)</arm_group_label>
    <arm_group_label>6-11 months: ETVAX (1/4)</arm_group_label>
    <arm_group_label>6-11 months: ETVAX (1/4) + 2.5 ug dmLT</arm_group_label>
    <arm_group_label>6-11 months: ETVAX (1/8)</arm_group_label>
    <arm_group_label>Adult: ETVAX (Full)</arm_group_label>
    <arm_group_label>Adult: ETVAX (Full) + 10 ug dmLT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>dmLT</intervention_name>
    <description>Varying dosages of dmLT, a derivative of wild-type enterotoxigenic Escherichia coli LT that has been genetically modified by replacing the arginine at amino acid position 192 with glycine and the leucine at amino acid position 211 with alanine. These two amino acid substitutions take place in proteolytic cleavage sites which are critical for activation of the secreted toxin molecules.</description>
    <arm_group_label>12-23 months: ETVAX (1/2) + 2.5 ug dmLT</arm_group_label>
    <arm_group_label>12-23 months: ETVAX (1/2) + 5 ug dmLT</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (1/2) + 10 ug dmLT</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (1/2) + 2.5 ug dmLT</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (1/2) + 5 ug dmLT</arm_group_label>
    <arm_group_label>6-11 month olds: ETVAX (1/4) + 5 ug dmLT</arm_group_label>
    <arm_group_label>6-11 months: ETVAX (1/4) + 2.5 ug dmLT</arm_group_label>
    <arm_group_label>Adult: ETVAX (Full) + 10 ug dmLT</arm_group_label>
    <other_name>double mutant heat labile toxin, LT(R192G/L211A)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bicarbonate Buffer</intervention_name>
    <description>Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
    <arm_group_label>12-23 months: ETVAX (1/2)</arm_group_label>
    <arm_group_label>12-23 months: ETVAX (1/2) + 2.5 ug dmLT</arm_group_label>
    <arm_group_label>12-23 months: ETVAX (1/2) + 5 ug dmLT</arm_group_label>
    <arm_group_label>12-23 months: ETVAX (1/4)</arm_group_label>
    <arm_group_label>12-23 months: Placebo</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (1/2)</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (1/2) + 10 ug dmLT</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (1/2) + 2.5 ug dmLT</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (1/2) + 5 ug dmLT</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (1/4)</arm_group_label>
    <arm_group_label>24-59 months: ETVAX (full)</arm_group_label>
    <arm_group_label>24-59 months: Placebo</arm_group_label>
    <arm_group_label>6-11 month olds: ETVAX (1/4) + 5 ug dmLT</arm_group_label>
    <arm_group_label>6-11 month olds: Placebo</arm_group_label>
    <arm_group_label>6-11 months: ETVAX (1/2)</arm_group_label>
    <arm_group_label>6-11 months: ETVAX (1/4)</arm_group_label>
    <arm_group_label>6-11 months: ETVAX (1/4) + 2.5 ug dmLT</arm_group_label>
    <arm_group_label>6-11 months: ETVAX (1/8)</arm_group_label>
    <arm_group_label>Adult: ETVAX (Full)</arm_group_label>
    <arm_group_label>Adult: ETVAX (Full) + 10 ug dmLT</arm_group_label>
    <arm_group_label>Adult: Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Adults

        Inclusion Criteria:

          1. Healthy male or female adults 18-45 years old, inclusive

          2. General good health as determined by the screening evaluation no greater than 7days
             before enrollment and vaccination

          3. Properly informed about the study, able to understand it and sign or thumb print the
             informed consent form

          4. Available for the entire period of the study and reachable by study staff throughout
             the entire follow-up period

          5. Females of childbearing potential who are willing to take a urine pregnancy test at
             screening and before the second vaccination. Pregnancy tests must be negative before
             each vaccination. Females of childbearing potential must agree to use an efficacious
             hormonal or barrier method of birth control during the study. Abstinence is also
             acceptable.

          6. Informed Consent (signature or thumb print provided, with witness signature)

        Exclusion Criteria:

          1. Presence of any significant known systemic disorder (cardiovascular, pulmonary,
             hepatic, renal, gastrointestinal, endocrine, immunological, dermatological,
             neurological, cancer or autoimmune disease) as determined by medical history and/or
             physical examination which would endanger the participant's health or is likely to
             result in non-conformance to the protocol.

          2. History of congenital abdominal disorders, intussusception, abdominal surgery or any
             other congenital disorder or presence of a significant medical condition that in the
             opinion of the Investigator precludes participation in the study. Known or suspected
             impairment of immunological function based on medical history and physical
             examination. Clinical evidence of active gastrointestinal illness and acute disease at
             the time of enrollment

          3. Screening positive with hepatitis B antigen and/or hepatitis C antibodies

          4. Participation in research involving another investigational product (defined as
             receipt of investigational product) during the 30 days before planned date of first
             vaccination or concurrently participating in another clinical study at any time during
             the study period, in which the participant has been or will be exposed to an
             investigational or a non-investigational product

          5. Clinically significant abnormalities in screening hematology or serum chemistry, as
             determined by the Study Physician

          6. History of febrile illness within 48 hours prior to vaccination and fever at the time
             of immunization (fever is defined as a temperature ≥ 37.5 C (99.5 F) on axillary,
             oral, or tympanic measurement)

          7. Prior receipt of any cholera (e.g., Dukoral, Shanchol) or ETEC vaccine

          8. Prior receipt of a blood transfusion or blood products, including immunoglobulins

          9. Evidence of current illicit drug use or drug dependence

         10. Current use of iron or zinc supplements within the past 7 days; current use of
             antacids (H2 blockers, omeprazole, over-the-counter (OTC) agents) or immunosuppressive
             drug

         11. Any condition which, in the opinion of the investigator, might jeopardize the safety
             of study participants or interfere with the evaluation of the study objectives

         12. Receipt of antimicrobial drugs for any reason within 14 days before vaccination

         13. History of diarrhea during the 7 days before vaccination (see protocol definition of
             diarrhea)

         14. Culture positive for ETEC, Shigella, V. Cholerae or Salmonella within 7 days before
             vaccination.

         15. Acute disease at the time of enrollment or 3 days prior to enrollment

         16. History of chronic administration (defined as more than 14 days) of immunosuppressant
             medications, including corticosteroids.

        Children, Toddlers and Infants Inclusion Criteria

          1. Healthy male or female infants/toddlers/children ages:

               -  Part B: &gt;24 and ≤59 months old at the time of enrollment

               -  Part C: ≥12 and &lt;24 months old at the time of enrollment

               -  Part D: ≥6 and &lt;12 months at the time of enrollment

          2. General good health as determined by the screening evaluation no greater than 7 days
             before enrollment and vaccination

          3. Parent properly informed about the study, able to understand it and sign or thumb
             print the informed consent form

          4. Parent and child available for the entire study period of the study and reachable by
             study staff throughout the entire follow-up period

          5. Informed Consent (signature or thumb of parent, with signature of witness, provided)

        Exclusion Criteria

          1. Presence of any significant known systemic disorder (cardiovascular, pulmonary,
             hepatic, renal, gastrointestinal, endocrine, immunological, dermatological,
             neurological, cancer or autoimmune disease) as determined by medical history and/or
             physical examination which would endanger the participant's health or is likely to
             result in non-conformance to the protocol.

          2. History of congenital abdominal disorders, intussusception, abdominal surgery or any
             other congenital disorder or presence of a significant medical condition that in the
             opinion of the Investigator precludes participation in the study. Known or suspected
             impairment of immunological function based on medical history and physical
             examination. Clinical evidence of active gastrointestinal illness and acute disease at
             the time of enrollment

          3. Screening positive with hepatitis B antigen and/or hepatitis C antibodies

          4. Participation in research involving another investigational product (defined as
             receipt of investigational product) during the 30 days before planned date of first
             vaccination or concurrently participating in another clinical study at any time during
             the study period, in which the participant has been or will be exposed to an
             investigational or a non-investigational product

          5. Clinically significant abnormalities in screening hematology or serum chemistry, as
             determined by the Study Physician

          6. History of febrile illness within 48 hours prior to vaccination and fever at the time
             of immunization (fever is defined as a temperature ≥ 37.5 C (99.5 F) on axillary,
             oral, or tympanic measurement)

          7. Prior receipt of any cholera (e.g., Dukoral, Shanchol) or ETEC vaccine

          8. Prior receipt of a blood transfusion or blood products, including immunoglobulins

          9. Current use of iron or zinc supplements within the past 7 days; current use of
             antacids (H2 blockers, omeprazole, OTC agents) or immunosuppressive drug

         10. Any condition which, in the opinion of the investigator, might jeopardize the safety
             of study participants or interfere with the evaluation of the study objectives

         11. Receipt of antimicrobial drugs for any reason within 14 days before vaccination

         12. History of diarrhea during the 7 days before vaccination (see Protocol definition of
             diarrhea))

         13. Culture positive for ETEC, Shigella, V. cholerae, Salmonella or Rotavirus (the latter
             for all children &lt;5 years of age) within 7 days of vaccination

         14. Acute disease at the time of enrollment or 3 days prior to enrollment

         15. Known or suspected impairment of immunological function based on medical history and
             physical examination

         16. Participant's parents/guardians not able, available or willing to accept active weekly
             follow-up by the study staff

         17. History of chronic administration (defined as more than 14 days) of immunosuppressant
             medications, including corticosteroids. Infants on inhaled or topical steroids may be
             permitted to participate in the study

         18. Any medical condition in the child/infant that, in the judgment of the investigator,
             would interfere with or serves as a contraindication to protocol adherence or a
             participant's parents' ability to give informed consent

         19. Medically significant malnutrition, defined as moderate malnutrition (wt-for-ht
             z-score between -3.0 and -2.0) and severe malnutrition (wt-for-ht z-score &lt;-3.0 or
             edema)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>International Centre for Diarrheal Disease, Bangladesh (icddr,b)</name>
      <address>
        <city>Dhaka</city>
        <zip>1212</zip>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>August 17, 2015</study_first_submitted>
  <study_first_submitted_qc>August 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2015</study_first_posted>
  <results_first_submitted>August 3, 2018</results_first_submitted>
  <results_first_submitted_qc>September 10, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">September 12, 2018</results_first_posted>
  <last_update_submitted>September 10, 2018</last_update_submitted>
  <last_update_submitted_qc>September 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ETEC diarrhea</keyword>
  <keyword>Escherichia Coli (ETEC)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 1, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/02/NCT02531802/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 8, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/02/NCT02531802/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Adult: ETVAX (Full)</title>
          <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P2">
          <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
          <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P3">
          <title>Adult: Placebo</title>
          <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
        </group>
        <group group_id="P4">
          <title>24-59 Months: ETVAX (1/4)</title>
          <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P5">
          <title>24-59 Months: ETVAX (1/2)</title>
          <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P6">
          <title>24-59 Months: ETVAX (Full)</title>
          <description>24-59 month old children receiving a full adult dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P7">
          <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
          <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P8">
          <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
          <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P9">
          <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
          <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P10">
          <title>24-59 Months: Placebo</title>
          <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
        </group>
        <group group_id="P11">
          <title>12-23 Months: ETVAX (1/4)</title>
          <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P12">
          <title>12-23 Months: ETVAX (1/2)</title>
          <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P13">
          <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
          <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P14">
          <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
          <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P15">
          <title>12-23 Months: Placebo</title>
          <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
        </group>
        <group group_id="P16">
          <title>6-11 Months: ETVAX (1/8)</title>
          <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P17">
          <title>6-11 Months: ETVAX (1/4)</title>
          <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P18">
          <title>6-11 Months: ETVAX (1/2)</title>
          <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P19">
          <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
          <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P20">
          <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
          <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="P21">
          <title>6-11 Month Olds: Placebo</title>
          <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Received Vaccination 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="15"/>
                <participants group_id="P4" count="15"/>
                <participants group_id="P5" count="15"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="15"/>
                <participants group_id="P8" count="15"/>
                <participants group_id="P9" count="15"/>
                <participants group_id="P10" count="52"/>
                <participants group_id="P11" count="15"/>
                <participants group_id="P12" count="15"/>
                <participants group_id="P13" count="15"/>
                <participants group_id="P14" count="15"/>
                <participants group_id="P15" count="40"/>
                <participants group_id="P16" count="30"/>
                <participants group_id="P17" count="30"/>
                <participants group_id="P18" count="30"/>
                <participants group_id="P19" count="30"/>
                <participants group_id="P20" count="30"/>
                <participants group_id="P21" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="15"/>
                <participants group_id="P4" count="15"/>
                <participants group_id="P5" count="15"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="15"/>
                <participants group_id="P8" count="15"/>
                <participants group_id="P9" count="15"/>
                <participants group_id="P10" count="52"/>
                <participants group_id="P11" count="15"/>
                <participants group_id="P12" count="15"/>
                <participants group_id="P13" count="15"/>
                <participants group_id="P14" count="15"/>
                <participants group_id="P15" count="40"/>
                <participants group_id="P16" count="30"/>
                <participants group_id="P17" count="30"/>
                <participants group_id="P18" count="30"/>
                <participants group_id="P19" count="30"/>
                <participants group_id="P20" count="30"/>
                <participants group_id="P21" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Received Vaccination 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="15"/>
                <participants group_id="P4" count="15"/>
                <participants group_id="P5" count="15"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="15"/>
                <participants group_id="P8" count="15"/>
                <participants group_id="P9" count="15"/>
                <participants group_id="P10" count="52"/>
                <participants group_id="P11" count="15"/>
                <participants group_id="P12" count="15"/>
                <participants group_id="P13" count="15"/>
                <participants group_id="P14" count="15"/>
                <participants group_id="P15" count="40"/>
                <participants group_id="P16" count="30"/>
                <participants group_id="P17" count="30"/>
                <participants group_id="P18" count="30"/>
                <participants group_id="P19" count="30"/>
                <participants group_id="P20" count="30"/>
                <participants group_id="P21" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="14"/>
                <participants group_id="P4" count="15"/>
                <participants group_id="P5" count="15"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="15"/>
                <participants group_id="P8" count="15"/>
                <participants group_id="P9" count="15"/>
                <participants group_id="P10" count="49"/>
                <participants group_id="P11" count="13"/>
                <participants group_id="P12" count="15"/>
                <participants group_id="P13" count="13"/>
                <participants group_id="P14" count="13"/>
                <participants group_id="P15" count="39"/>
                <participants group_id="P16" count="30"/>
                <participants group_id="P17" count="30"/>
                <participants group_id="P18" count="26"/>
                <participants group_id="P19" count="27"/>
                <participants group_id="P20" count="29"/>
                <participants group_id="P21" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="3"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="2"/>
                <participants group_id="P14" count="2"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="4"/>
                <participants group_id="P19" count="3"/>
                <participants group_id="P20" count="1"/>
                <participants group_id="P21" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Medication interfering with study taken</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="1"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="2"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="1"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="2"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="1"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="1"/>
                <participants group_id="P19" count="1"/>
                <participants group_id="P20" count="1"/>
                <participants group_id="P21" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Adult: Placebo</title>
          <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
        </group>
        <group group_id="B2">
          <title>Adult: ETVAX (Full)</title>
          <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B3">
          <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
          <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B4">
          <title>24-59 Months: Placebo</title>
          <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
        </group>
        <group group_id="B5">
          <title>24-59 Months: ETVAX (1/4)</title>
          <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B6">
          <title>24-59 Months: ETVAX (1/2)</title>
          <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B7">
          <title>24-59 Months: ETVAX (Full)</title>
          <description>24-59 month old children receiving a full adult dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B8">
          <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
          <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B9">
          <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
          <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B10">
          <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
          <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B11">
          <title>12-23 Months: Placebo</title>
          <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
        </group>
        <group group_id="B12">
          <title>12-23 Months: ETVAX (1/4)</title>
          <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B13">
          <title>12-23 Months: ETVAX (1/2)</title>
          <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B14">
          <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
          <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B15">
          <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
          <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B16">
          <title>6-11 Month Olds: Placebo</title>
          <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
        </group>
        <group group_id="B17">
          <title>6-11 Months: ETVAX (1/8)</title>
          <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B18">
          <title>6-11 Months: ETVAX (1/4)</title>
          <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B19">
          <title>6-11 Months: ETVAX (1/2)</title>
          <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B20">
          <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
          <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B21">
          <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
          <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="B22">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="15"/>
            <count group_id="B4" value="52"/>
            <count group_id="B5" value="15"/>
            <count group_id="B6" value="15"/>
            <count group_id="B7" value="3"/>
            <count group_id="B8" value="15"/>
            <count group_id="B9" value="15"/>
            <count group_id="B10" value="15"/>
            <count group_id="B11" value="40"/>
            <count group_id="B12" value="15"/>
            <count group_id="B13" value="15"/>
            <count group_id="B14" value="15"/>
            <count group_id="B15" value="15"/>
            <count group_id="B16" value="50"/>
            <count group_id="B17" value="30"/>
            <count group_id="B18" value="30"/>
            <count group_id="B19" value="30"/>
            <count group_id="B20" value="30"/>
            <count group_id="B21" value="30"/>
            <count group_id="B22" value="475"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.5" spread="5.58"/>
                    <measurement group_id="B2" value="30.1" spread="6.96"/>
                    <measurement group_id="B3" value="29.4" spread="6.96"/>
                    <measurement group_id="B4" value="3.7" spread="0.77"/>
                    <measurement group_id="B5" value="4.1" spread="0.62"/>
                    <measurement group_id="B6" value="3.4" spread="0.68"/>
                    <measurement group_id="B7" value="4.2" spread="0.59"/>
                    <measurement group_id="B8" value="3.4" spread="0.86"/>
                    <measurement group_id="B9" value="3.6" spread="0.91"/>
                    <measurement group_id="B10" value="3.4" spread="0.73"/>
                    <measurement group_id="B11" value="1.4" spread="0.27"/>
                    <measurement group_id="B12" value="1.3" spread="0.21"/>
                    <measurement group_id="B13" value="1.5" spread="0.30"/>
                    <measurement group_id="B14" value="1.6" spread="0.28"/>
                    <measurement group_id="B15" value="1.4" spread="0.27"/>
                    <measurement group_id="B16" value="0.7" spread="0.13"/>
                    <measurement group_id="B17" value="0.7" spread="0.15"/>
                    <measurement group_id="B18" value="0.7" spread="0.14"/>
                    <measurement group_id="B19" value="0.7" spread="0.11"/>
                    <measurement group_id="B20" value="0.7" spread="0.15"/>
                    <measurement group_id="B21" value="0.6" spread="0.10"/>
                    <measurement group_id="B22" value="4.4" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="26"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="6"/>
                    <measurement group_id="B9" value="7"/>
                    <measurement group_id="B10" value="9"/>
                    <measurement group_id="B11" value="20"/>
                    <measurement group_id="B12" value="6"/>
                    <measurement group_id="B13" value="5"/>
                    <measurement group_id="B14" value="7"/>
                    <measurement group_id="B15" value="10"/>
                    <measurement group_id="B16" value="23"/>
                    <measurement group_id="B17" value="14"/>
                    <measurement group_id="B18" value="19"/>
                    <measurement group_id="B19" value="16"/>
                    <measurement group_id="B20" value="18"/>
                    <measurement group_id="B21" value="16"/>
                    <measurement group_id="B22" value="249"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="26"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="9"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="9"/>
                    <measurement group_id="B9" value="8"/>
                    <measurement group_id="B10" value="6"/>
                    <measurement group_id="B11" value="20"/>
                    <measurement group_id="B12" value="9"/>
                    <measurement group_id="B13" value="10"/>
                    <measurement group_id="B14" value="8"/>
                    <measurement group_id="B15" value="5"/>
                    <measurement group_id="B16" value="27"/>
                    <measurement group_id="B17" value="16"/>
                    <measurement group_id="B18" value="11"/>
                    <measurement group_id="B19" value="14"/>
                    <measurement group_id="B20" value="12"/>
                    <measurement group_id="B21" value="14"/>
                    <measurement group_id="B22" value="226"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="52"/>
                    <measurement group_id="B5" value="15"/>
                    <measurement group_id="B6" value="15"/>
                    <measurement group_id="B7" value="3"/>
                    <measurement group_id="B8" value="15"/>
                    <measurement group_id="B9" value="15"/>
                    <measurement group_id="B10" value="15"/>
                    <measurement group_id="B11" value="40"/>
                    <measurement group_id="B12" value="15"/>
                    <measurement group_id="B13" value="15"/>
                    <measurement group_id="B14" value="15"/>
                    <measurement group_id="B15" value="15"/>
                    <measurement group_id="B16" value="50"/>
                    <measurement group_id="B17" value="30"/>
                    <measurement group_id="B18" value="30"/>
                    <measurement group_id="B19" value="30"/>
                    <measurement group_id="B20" value="30"/>
                    <measurement group_id="B21" value="30"/>
                    <measurement group_id="B22" value="475"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="154.69" spread="8.01"/>
                    <measurement group_id="B2" value="155.29" spread="9.38"/>
                    <measurement group_id="B3" value="154.26" spread="10.16"/>
                    <measurement group_id="B4" value="97.02" spread="6.84"/>
                    <measurement group_id="B5" value="97.73" spread="5.33"/>
                    <measurement group_id="B6" value="93.73" spread="7.08"/>
                    <measurement group_id="B7" value="96.67" spread="2.52"/>
                    <measurement group_id="B8" value="90.33" spread="6.11"/>
                    <measurement group_id="B9" value="94.13" spread="7.27"/>
                    <measurement group_id="B10" value="92.2" spread="6.59"/>
                    <measurement group_id="B11" value="77.83" spread="4.60"/>
                    <measurement group_id="B12" value="76.27" spread="2.99"/>
                    <measurement group_id="B13" value="79.33" spread="4.27"/>
                    <measurement group_id="B14" value="79.2" spread="4.69"/>
                    <measurement group_id="B15" value="76.6" spread="2.59"/>
                    <measurement group_id="B16" value="67.64" spread="3.44"/>
                    <measurement group_id="B17" value="68.83" spread="3.04"/>
                    <measurement group_id="B18" value="67.77" spread="3.45"/>
                    <measurement group_id="B19" value="68.83" spread="3.04"/>
                    <measurement group_id="B20" value="66.73" spread="3.14"/>
                    <measurement group_id="B21" value="67.57" spread="2.58"/>
                    <measurement group_id="B22" value="85.6" spread="25.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.65" spread="9.867"/>
                    <measurement group_id="B2" value="56.86" spread="11.776"/>
                    <measurement group_id="B3" value="55.25" spread="11.441"/>
                    <measurement group_id="B4" value="13.71" spread="2.043"/>
                    <measurement group_id="B5" value="13.59" spread="1.488"/>
                    <measurement group_id="B6" value="13.61" spread="1.914"/>
                    <measurement group_id="B7" value="12.43" spread="0.513"/>
                    <measurement group_id="B8" value="12.1" spread="1.465"/>
                    <measurement group_id="B9" value="13.35" spread="1.957"/>
                    <measurement group_id="B10" value="12.61" spread="1.936"/>
                    <measurement group_id="B11" value="9.47" spread="1.226"/>
                    <measurement group_id="B12" value="9.23" spread="0.959"/>
                    <measurement group_id="B13" value="9.64" spread="0.946"/>
                    <measurement group_id="B14" value="9.5" spread="1.271"/>
                    <measurement group_id="B15" value="9.24" spread="0.998"/>
                    <measurement group_id="B16" value="7.66" spread="0.958"/>
                    <measurement group_id="B17" value="7.84" spread="1.006"/>
                    <measurement group_id="B18" value="7.37" spread="0.728"/>
                    <measurement group_id="B19" value="7.85" spread="1.226"/>
                    <measurement group_id="B20" value="7.41" spread="0.876"/>
                    <measurement group_id="B21" value="7.76" spread="0.598"/>
                    <measurement group_id="B22" value="14.2" spread="14.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number and Percentage of Participants Experiencing Solicited Events by Symptom and Maximum Severity</title>
        <description>Adverse events (AEs) were assessed post-vaccination using participant/parent/guardian interview (including memory aids), targeted physical examinations, vital signs and clinical laboratory tests and reactogenicity assessments which were completed following each vaccination. The solicited AEs of nausea (adults only), abdominal pain/stomach ache (adults and children 24-59 months only), fever, vomiting and diarrhea were evaluated daily for 7 days post vaccination.</description>
        <time_frame>7 days after each vaccination (Day 7 and Day 21)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (Full)</title>
            <description>24-59 month old children receiving a full adult dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O10">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O15">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O21">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of Participants Experiencing Solicited Events by Symptom and Maximum Severity</title>
          <description>Adverse events (AEs) were assessed post-vaccination using participant/parent/guardian interview (including memory aids), targeted physical examinations, vital signs and clinical laboratory tests and reactogenicity assessments which were completed following each vaccination. The solicited AEs of nausea (adults only), abdominal pain/stomach ache (adults and children 24-59 months only), fever, vomiting and diarrhea were evaluated daily for 7 days post vaccination.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="15"/>
                <count group_id="O10" value="52"/>
                <count group_id="O11" value="15"/>
                <count group_id="O12" value="15"/>
                <count group_id="O13" value="15"/>
                <count group_id="O14" value="15"/>
                <count group_id="O15" value="40"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="30"/>
                <count group_id="O18" value="30"/>
                <count group_id="O19" value="30"/>
                <count group_id="O20" value="30"/>
                <count group_id="O21" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Elevated oral temperature</title>
              <category_list>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="15"/>
                    <measurement group_id="O10" value="50"/>
                    <measurement group_id="O11" value="14"/>
                    <measurement group_id="O12" value="15"/>
                    <measurement group_id="O13" value="12"/>
                    <measurement group_id="O14" value="14"/>
                    <measurement group_id="O15" value="39"/>
                    <measurement group_id="O16" value="28"/>
                    <measurement group_id="O17" value="28"/>
                    <measurement group_id="O18" value="28"/>
                    <measurement group_id="O19" value="28"/>
                    <measurement group_id="O20" value="27"/>
                    <measurement group_id="O21" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="2"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="2"/>
                    <measurement group_id="O18" value="1"/>
                    <measurement group_id="O19" value="2"/>
                    <measurement group_id="O20" value="3"/>
                    <measurement group_id="O21" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="1"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting</title>
              <category_list>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="14"/>
                    <measurement group_id="O9" value="12"/>
                    <measurement group_id="O10" value="52"/>
                    <measurement group_id="O11" value="13"/>
                    <measurement group_id="O12" value="14"/>
                    <measurement group_id="O13" value="13"/>
                    <measurement group_id="O14" value="7"/>
                    <measurement group_id="O15" value="40"/>
                    <measurement group_id="O16" value="28"/>
                    <measurement group_id="O17" value="25"/>
                    <measurement group_id="O18" value="20"/>
                    <measurement group_id="O19" value="23"/>
                    <measurement group_id="O20" value="25"/>
                    <measurement group_id="O21" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="2"/>
                    <measurement group_id="O14" value="8"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="5"/>
                    <measurement group_id="O18" value="8"/>
                    <measurement group_id="O19" value="6"/>
                    <measurement group_id="O20" value="5"/>
                    <measurement group_id="O21" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="2"/>
                    <measurement group_id="O19" value="1"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Loose stools</title>
              <category_list>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="15"/>
                    <measurement group_id="O10" value="52"/>
                    <measurement group_id="O11" value="15"/>
                    <measurement group_id="O12" value="15"/>
                    <measurement group_id="O13" value="12"/>
                    <measurement group_id="O14" value="15"/>
                    <measurement group_id="O15" value="40"/>
                    <measurement group_id="O16" value="30"/>
                    <measurement group_id="O17" value="29"/>
                    <measurement group_id="O18" value="29"/>
                    <measurement group_id="O19" value="30"/>
                    <measurement group_id="O20" value="30"/>
                    <measurement group_id="O21" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="1"/>
                    <measurement group_id="O18" value="1"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abdominal pain/stomach ache</title>
              <category_list>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="15"/>
                    <measurement group_id="O10" value="52"/>
                    <measurement group_id="O11" value="15"/>
                    <measurement group_id="O12" value="15"/>
                    <measurement group_id="O13" value="15"/>
                    <measurement group_id="O14" value="15"/>
                    <measurement group_id="O15" value="40"/>
                    <measurement group_id="O16" value="30"/>
                    <measurement group_id="O17" value="30"/>
                    <measurement group_id="O18" value="30"/>
                    <measurement group_id="O19" value="30"/>
                    <measurement group_id="O20" value="30"/>
                    <measurement group_id="O21" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea</title>
              <category_list>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="15"/>
                    <measurement group_id="O10" value="52"/>
                    <measurement group_id="O11" value="14"/>
                    <measurement group_id="O12" value="14"/>
                    <measurement group_id="O13" value="15"/>
                    <measurement group_id="O14" value="14"/>
                    <measurement group_id="O15" value="40"/>
                    <measurement group_id="O16" value="30"/>
                    <measurement group_id="O17" value="30"/>
                    <measurement group_id="O18" value="28"/>
                    <measurement group_id="O19" value="29"/>
                    <measurement group_id="O20" value="29"/>
                    <measurement group_id="O21" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="2"/>
                    <measurement group_id="O19" value="1"/>
                    <measurement group_id="O20" value="1"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Acute systemic allergic reaction</title>
              <category_list>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="15"/>
                    <measurement group_id="O10" value="52"/>
                    <measurement group_id="O11" value="15"/>
                    <measurement group_id="O12" value="15"/>
                    <measurement group_id="O13" value="15"/>
                    <measurement group_id="O14" value="15"/>
                    <measurement group_id="O15" value="40"/>
                    <measurement group_id="O16" value="30"/>
                    <measurement group_id="O17" value="30"/>
                    <measurement group_id="O18" value="30"/>
                    <measurement group_id="O19" value="30"/>
                    <measurement group_id="O20" value="30"/>
                    <measurement group_id="O21" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea</title>
              <category_list>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="15"/>
                    <measurement group_id="O10" value="52"/>
                    <measurement group_id="O11" value="15"/>
                    <measurement group_id="O12" value="15"/>
                    <measurement group_id="O13" value="15"/>
                    <measurement group_id="O14" value="15"/>
                    <measurement group_id="O15" value="40"/>
                    <measurement group_id="O16" value="30"/>
                    <measurement group_id="O17" value="30"/>
                    <measurement group_id="O18" value="30"/>
                    <measurement group_id="O19" value="30"/>
                    <measurement group_id="O20" value="30"/>
                    <measurement group_id="O21" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any symptom</title>
              <category_list>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="14"/>
                    <measurement group_id="O9" value="12"/>
                    <measurement group_id="O10" value="50"/>
                    <measurement group_id="O11" value="12"/>
                    <measurement group_id="O12" value="13"/>
                    <measurement group_id="O13" value="9"/>
                    <measurement group_id="O14" value="7"/>
                    <measurement group_id="O15" value="40"/>
                    <measurement group_id="O16" value="26"/>
                    <measurement group_id="O17" value="23"/>
                    <measurement group_id="O18" value="17"/>
                    <measurement group_id="O19" value="22"/>
                    <measurement group_id="O20" value="22"/>
                    <measurement group_id="O21" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="2"/>
                    <measurement group_id="O13" value="5"/>
                    <measurement group_id="O14" value="8"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="4"/>
                    <measurement group_id="O17" value="7"/>
                    <measurement group_id="O18" value="10"/>
                    <measurement group_id="O19" value="7"/>
                    <measurement group_id="O20" value="8"/>
                    <measurement group_id="O21" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="3"/>
                    <measurement group_id="O19" value="1"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number and Percentage of Participants Experiencing Unsolicited Adverse Events Related to Vaccine</title>
        <description>Adverse events (AEs) were assessed post-vaccination using participant/parent/guardian interview (including memory aids), targeted physical examinations, vital signs and clinical laboratory tests and reactogenicity assessments which were completed following each vaccination. Unsolicited AEs were assessed through Day 42 and serious adverse events (SAEs) were assessed over the entire duration of the study.</description>
        <time_frame>6 months ± 14 days after the first dose</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (Full)</title>
            <description>24-59 month old children receiving a full adult dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O10">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O15">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O21">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of Participants Experiencing Unsolicited Adverse Events Related to Vaccine</title>
          <description>Adverse events (AEs) were assessed post-vaccination using participant/parent/guardian interview (including memory aids), targeted physical examinations, vital signs and clinical laboratory tests and reactogenicity assessments which were completed following each vaccination. Unsolicited AEs were assessed through Day 42 and serious adverse events (SAEs) were assessed over the entire duration of the study.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="15"/>
                <count group_id="O10" value="52"/>
                <count group_id="O11" value="15"/>
                <count group_id="O12" value="15"/>
                <count group_id="O13" value="15"/>
                <count group_id="O14" value="15"/>
                <count group_id="O15" value="40"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="30"/>
                <count group_id="O18" value="30"/>
                <count group_id="O19" value="30"/>
                <count group_id="O20" value="30"/>
                <count group_id="O21" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Leukocytosis</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="2"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No AE related to vaccine</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="15"/>
                    <measurement group_id="O10" value="52"/>
                    <measurement group_id="O11" value="14"/>
                    <measurement group_id="O12" value="15"/>
                    <measurement group_id="O13" value="14"/>
                    <measurement group_id="O14" value="15"/>
                    <measurement group_id="O15" value="38"/>
                    <measurement group_id="O16" value="30"/>
                    <measurement group_id="O17" value="30"/>
                    <measurement group_id="O18" value="30"/>
                    <measurement group_id="O19" value="30"/>
                    <measurement group_id="O20" value="30"/>
                    <measurement group_id="O21" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Alanine aminotransferase increased</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No AE related to vaccine</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="15"/>
                    <measurement group_id="O10" value="52"/>
                    <measurement group_id="O11" value="15"/>
                    <measurement group_id="O12" value="15"/>
                    <measurement group_id="O13" value="15"/>
                    <measurement group_id="O14" value="15"/>
                    <measurement group_id="O15" value="39"/>
                    <measurement group_id="O16" value="30"/>
                    <measurement group_id="O17" value="30"/>
                    <measurement group_id="O18" value="30"/>
                    <measurement group_id="O19" value="30"/>
                    <measurement group_id="O20" value="30"/>
                    <measurement group_id="O21" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of Subjects With ≥Two-fold Increase in Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Response After Either Vaccine Dose, by Antigen</title>
        <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O10">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O15">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of Subjects With ≥Two-fold Increase in Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Response After Either Vaccine Dose, by Antigen</title>
          <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="49"/>
                <count group_id="O10" value="13"/>
                <count group_id="O11" value="15"/>
                <count group_id="O12" value="13"/>
                <count group_id="O13" value="13"/>
                <count group_id="O14" value="39"/>
                <count group_id="O15" value="30"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="24"/>
                <count group_id="O18" value="26"/>
                <count group_id="O19" value="29"/>
                <count group_id="O20" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="15"/>
                    <measurement group_id="O7" value="14"/>
                    <measurement group_id="O8" value="13"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="11"/>
                    <measurement group_id="O11" value="11"/>
                    <measurement group_id="O12" value="9"/>
                    <measurement group_id="O13" value="9"/>
                    <measurement group_id="O14" value="3"/>
                    <measurement group_id="O15" value="15"/>
                    <measurement group_id="O16" value="9"/>
                    <measurement group_id="O17" value="12"/>
                    <measurement group_id="O18" value="10"/>
                    <measurement group_id="O19" value="7"/>
                    <measurement group_id="O20" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="46"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="4"/>
                    <measurement group_id="O13" value="4"/>
                    <measurement group_id="O14" value="36"/>
                    <measurement group_id="O15" value="15"/>
                    <measurement group_id="O16" value="21"/>
                    <measurement group_id="O17" value="12"/>
                    <measurement group_id="O18" value="16"/>
                    <measurement group_id="O19" value="22"/>
                    <measurement group_id="O20" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="15"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="7"/>
                    <measurement group_id="O10" value="11"/>
                    <measurement group_id="O11" value="13"/>
                    <measurement group_id="O12" value="12"/>
                    <measurement group_id="O13" value="7"/>
                    <measurement group_id="O14" value="6"/>
                    <measurement group_id="O15" value="15"/>
                    <measurement group_id="O16" value="13"/>
                    <measurement group_id="O17" value="13"/>
                    <measurement group_id="O18" value="13"/>
                    <measurement group_id="O19" value="11"/>
                    <measurement group_id="O20" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="42"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="6"/>
                    <measurement group_id="O14" value="33"/>
                    <measurement group_id="O15" value="15"/>
                    <measurement group_id="O16" value="17"/>
                    <measurement group_id="O17" value="11"/>
                    <measurement group_id="O18" value="13"/>
                    <measurement group_id="O19" value="18"/>
                    <measurement group_id="O20" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="11"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="8"/>
                    <measurement group_id="O11" value="7"/>
                    <measurement group_id="O12" value="6"/>
                    <measurement group_id="O13" value="8"/>
                    <measurement group_id="O14" value="3"/>
                    <measurement group_id="O15" value="11"/>
                    <measurement group_id="O16" value="6"/>
                    <measurement group_id="O17" value="5"/>
                    <measurement group_id="O18" value="5"/>
                    <measurement group_id="O19" value="3"/>
                    <measurement group_id="O20" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="47"/>
                    <measurement group_id="O10" value="5"/>
                    <measurement group_id="O11" value="8"/>
                    <measurement group_id="O12" value="7"/>
                    <measurement group_id="O13" value="5"/>
                    <measurement group_id="O14" value="36"/>
                    <measurement group_id="O15" value="19"/>
                    <measurement group_id="O16" value="24"/>
                    <measurement group_id="O17" value="19"/>
                    <measurement group_id="O18" value="21"/>
                    <measurement group_id="O19" value="26"/>
                    <measurement group_id="O20" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="12"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="14"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="10"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="6"/>
                    <measurement group_id="O11" value="5"/>
                    <measurement group_id="O12" value="9"/>
                    <measurement group_id="O13" value="5"/>
                    <measurement group_id="O14" value="5"/>
                    <measurement group_id="O15" value="3"/>
                    <measurement group_id="O16" value="5"/>
                    <measurement group_id="O17" value="5"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="5"/>
                    <measurement group_id="O9" value="48"/>
                    <measurement group_id="O10" value="6"/>
                    <measurement group_id="O11" value="10"/>
                    <measurement group_id="O12" value="4"/>
                    <measurement group_id="O13" value="8"/>
                    <measurement group_id="O14" value="34"/>
                    <measurement group_id="O15" value="27"/>
                    <measurement group_id="O16" value="25"/>
                    <measurement group_id="O17" value="19"/>
                    <measurement group_id="O18" value="26"/>
                    <measurement group_id="O19" value="29"/>
                    <measurement group_id="O20" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="15"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="13"/>
                    <measurement group_id="O11" value="15"/>
                    <measurement group_id="O12" value="13"/>
                    <measurement group_id="O13" value="11"/>
                    <measurement group_id="O14" value="6"/>
                    <measurement group_id="O15" value="19"/>
                    <measurement group_id="O16" value="24"/>
                    <measurement group_id="O17" value="20"/>
                    <measurement group_id="O18" value="18"/>
                    <measurement group_id="O19" value="21"/>
                    <measurement group_id="O20" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="45"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="2"/>
                    <measurement group_id="O14" value="33"/>
                    <measurement group_id="O15" value="11"/>
                    <measurement group_id="O16" value="6"/>
                    <measurement group_id="O17" value="4"/>
                    <measurement group_id="O18" value="8"/>
                    <measurement group_id="O19" value="8"/>
                    <measurement group_id="O20" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of Subjects With ≥Four-fold Increase in Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Response After Either Vaccine Dose, by Antigen</title>
        <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O10">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O15">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of Subjects With ≥Four-fold Increase in Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Response After Either Vaccine Dose, by Antigen</title>
          <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="49"/>
                <count group_id="O10" value="13"/>
                <count group_id="O11" value="15"/>
                <count group_id="O12" value="13"/>
                <count group_id="O13" value="13"/>
                <count group_id="O14" value="39"/>
                <count group_id="O15" value="30"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="24"/>
                <count group_id="O18" value="26"/>
                <count group_id="O19" value="29"/>
                <count group_id="O20" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="14"/>
                    <measurement group_id="O7" value="14"/>
                    <measurement group_id="O8" value="12"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="10"/>
                    <measurement group_id="O11" value="10"/>
                    <measurement group_id="O12" value="7"/>
                    <measurement group_id="O13" value="7"/>
                    <measurement group_id="O14" value="3"/>
                    <measurement group_id="O15" value="10"/>
                    <measurement group_id="O16" value="7"/>
                    <measurement group_id="O17" value="9"/>
                    <measurement group_id="O18" value="9"/>
                    <measurement group_id="O19" value="4"/>
                    <measurement group_id="O20" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="48"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="5"/>
                    <measurement group_id="O12" value="6"/>
                    <measurement group_id="O13" value="6"/>
                    <measurement group_id="O14" value="36"/>
                    <measurement group_id="O15" value="20"/>
                    <measurement group_id="O16" value="23"/>
                    <measurement group_id="O17" value="15"/>
                    <measurement group_id="O18" value="17"/>
                    <measurement group_id="O19" value="25"/>
                    <measurement group_id="O20" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="15"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="6"/>
                    <measurement group_id="O10" value="7"/>
                    <measurement group_id="O11" value="11"/>
                    <measurement group_id="O12" value="11"/>
                    <measurement group_id="O13" value="6"/>
                    <measurement group_id="O14" value="3"/>
                    <measurement group_id="O15" value="10"/>
                    <measurement group_id="O16" value="7"/>
                    <measurement group_id="O17" value="7"/>
                    <measurement group_id="O18" value="7"/>
                    <measurement group_id="O19" value="8"/>
                    <measurement group_id="O20" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="43"/>
                    <measurement group_id="O10" value="6"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="2"/>
                    <measurement group_id="O13" value="7"/>
                    <measurement group_id="O14" value="36"/>
                    <measurement group_id="O15" value="20"/>
                    <measurement group_id="O16" value="23"/>
                    <measurement group_id="O17" value="17"/>
                    <measurement group_id="O18" value="19"/>
                    <measurement group_id="O19" value="21"/>
                    <measurement group_id="O20" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="9"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="6"/>
                    <measurement group_id="O11" value="7"/>
                    <measurement group_id="O12" value="5"/>
                    <measurement group_id="O13" value="8"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="8"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="3"/>
                    <measurement group_id="O18" value="3"/>
                    <measurement group_id="O19" value="2"/>
                    <measurement group_id="O20" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="6"/>
                    <measurement group_id="O9" value="48"/>
                    <measurement group_id="O10" value="7"/>
                    <measurement group_id="O11" value="8"/>
                    <measurement group_id="O12" value="8"/>
                    <measurement group_id="O13" value="5"/>
                    <measurement group_id="O14" value="38"/>
                    <measurement group_id="O15" value="22"/>
                    <measurement group_id="O16" value="28"/>
                    <measurement group_id="O17" value="21"/>
                    <measurement group_id="O18" value="23"/>
                    <measurement group_id="O19" value="27"/>
                    <measurement group_id="O20" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="12"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="8"/>
                    <measurement group_id="O8" value="9"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="8"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="2"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="1"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="6"/>
                    <measurement group_id="O9" value="49"/>
                    <measurement group_id="O10" value="9"/>
                    <measurement group_id="O11" value="11"/>
                    <measurement group_id="O12" value="5"/>
                    <measurement group_id="O13" value="10"/>
                    <measurement group_id="O14" value="38"/>
                    <measurement group_id="O15" value="28"/>
                    <measurement group_id="O16" value="29"/>
                    <measurement group_id="O17" value="24"/>
                    <measurement group_id="O18" value="26"/>
                    <measurement group_id="O19" value="28"/>
                    <measurement group_id="O20" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="15"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="14"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="11"/>
                    <measurement group_id="O11" value="15"/>
                    <measurement group_id="O12" value="13"/>
                    <measurement group_id="O13" value="11"/>
                    <measurement group_id="O14" value="3"/>
                    <measurement group_id="O15" value="15"/>
                    <measurement group_id="O16" value="20"/>
                    <measurement group_id="O17" value="18"/>
                    <measurement group_id="O18" value="15"/>
                    <measurement group_id="O19" value="19"/>
                    <measurement group_id="O20" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="47"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="2"/>
                    <measurement group_id="O14" value="36"/>
                    <measurement group_id="O15" value="15"/>
                    <measurement group_id="O16" value="10"/>
                    <measurement group_id="O17" value="6"/>
                    <measurement group_id="O18" value="11"/>
                    <measurement group_id="O19" value="10"/>
                    <measurement group_id="O20" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Titer (GMT) of Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Response After Either Vaccine Dose, by Antigen</title>
        <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O10">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O15">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Titer (GMT) of Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Response After Either Vaccine Dose, by Antigen</title>
          <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="49"/>
                <count group_id="O10" value="13"/>
                <count group_id="O11" value="15"/>
                <count group_id="O12" value="13"/>
                <count group_id="O13" value="13"/>
                <count group_id="O14" value="39"/>
                <count group_id="O15" value="30"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="24"/>
                <count group_id="O18" value="26"/>
                <count group_id="O19" value="29"/>
                <count group_id="O20" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9991" lower_limit="5436" upper_limit="18363"/>
                    <measurement group_id="O2" value="6732" lower_limit="4023" upper_limit="11264"/>
                    <measurement group_id="O3" value="115" lower_limit="96.6" upper_limit="137"/>
                    <measurement group_id="O4" value="7298" lower_limit="3881" upper_limit="13724"/>
                    <measurement group_id="O5" value="2913" lower_limit="1051" upper_limit="8072"/>
                    <measurement group_id="O6" value="7819" lower_limit="3265" upper_limit="18726"/>
                    <measurement group_id="O7" value="2239" lower_limit="980" upper_limit="5114"/>
                    <measurement group_id="O8" value="3164" lower_limit="1014" upper_limit="9878"/>
                    <measurement group_id="O9" value="149" lower_limit="135" upper_limit="165"/>
                    <measurement group_id="O10" value="1490" lower_limit="594" upper_limit="3741"/>
                    <measurement group_id="O11" value="2937" lower_limit="783" upper_limit="11013"/>
                    <measurement group_id="O12" value="577" lower_limit="175" upper_limit="1900"/>
                    <measurement group_id="O13" value="862" lower_limit="262" upper_limit="2842"/>
                    <measurement group_id="O14" value="155" lower_limit="108" upper_limit="222"/>
                    <measurement group_id="O15" value="318" lower_limit="156" upper_limit="649"/>
                    <measurement group_id="O16" value="228" lower_limit="108" upper_limit="480"/>
                    <measurement group_id="O17" value="328" lower_limit="143" upper_limit="755"/>
                    <measurement group_id="O18" value="202" lower_limit="94.7" upper_limit="429"/>
                    <measurement group_id="O19" value="123" lower_limit="79.3" upper_limit="191"/>
                    <measurement group_id="O20" value="104" lower_limit="78.8" upper_limit="138"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11354" lower_limit="6183" upper_limit="20848"/>
                    <measurement group_id="O2" value="7658" lower_limit="4208" upper_limit="13937"/>
                    <measurement group_id="O3" value="221" lower_limit="115" upper_limit="424"/>
                    <measurement group_id="O4" value="9277" lower_limit="4408" upper_limit="19525"/>
                    <measurement group_id="O5" value="2283" lower_limit="923" upper_limit="5646"/>
                    <measurement group_id="O6" value="4868" lower_limit="2564" upper_limit="9243"/>
                    <measurement group_id="O7" value="1400" lower_limit="639" upper_limit="3063"/>
                    <measurement group_id="O8" value="4076" lower_limit="2240" upper_limit="7419"/>
                    <measurement group_id="O9" value="190" lower_limit="154" upper_limit="234"/>
                    <measurement group_id="O10" value="600" lower_limit="240" upper_limit="1502"/>
                    <measurement group_id="O11" value="1322" lower_limit="601" upper_limit="2906"/>
                    <measurement group_id="O12" value="1346" lower_limit="470" upper_limit="3853"/>
                    <measurement group_id="O13" value="700" lower_limit="208" upper_limit="2360"/>
                    <measurement group_id="O14" value="134" lower_limit="106" upper_limit="169"/>
                    <measurement group_id="O15" value="355" lower_limit="198" upper_limit="639"/>
                    <measurement group_id="O16" value="263" lower_limit="138" upper_limit="501"/>
                    <measurement group_id="O17" value="212" lower_limit="122" upper_limit="368"/>
                    <measurement group_id="O18" value="186" lower_limit="116" upper_limit="298"/>
                    <measurement group_id="O19" value="196" lower_limit="118" upper_limit="324"/>
                    <measurement group_id="O20" value="123" lower_limit="92.8" upper_limit="164"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4405" lower_limit="2264" upper_limit="8573"/>
                    <measurement group_id="O2" value="5198" lower_limit="2647" upper_limit="10204"/>
                    <measurement group_id="O3" value="101" lower_limit="87.9" upper_limit="116"/>
                    <measurement group_id="O4" value="4869" lower_limit="1987" upper_limit="11930"/>
                    <measurement group_id="O5" value="1473" lower_limit="689" upper_limit="3148"/>
                    <measurement group_id="O6" value="1921" lower_limit="620" upper_limit="5955"/>
                    <measurement group_id="O7" value="876" lower_limit="357" upper_limit="2145"/>
                    <measurement group_id="O8" value="913" lower_limit="246" upper_limit="3386"/>
                    <measurement group_id="O9" value="96.3" lower_limit="86.8" upper_limit="107"/>
                    <measurement group_id="O10" value="369" lower_limit="140" upper_limit="973"/>
                    <measurement group_id="O11" value="394" lower_limit="144" upper_limit="1076"/>
                    <measurement group_id="O12" value="229" lower_limit="89.8" upper_limit="586"/>
                    <measurement group_id="O13" value="616" lower_limit="200" upper_limit="1897"/>
                    <measurement group_id="O14" value="83.3" lower_limit="73.9" upper_limit="94.0"/>
                    <measurement group_id="O15" value="163" lower_limit="102" upper_limit="261"/>
                    <measurement group_id="O16" value="100" lower_limit="71.0" upper_limit="141"/>
                    <measurement group_id="O17" value="190" lower_limit="144" upper_limit="251"/>
                    <measurement group_id="O18" value="90.4" lower_limit="64.8" upper_limit="126"/>
                    <measurement group_id="O19" value="81.5" lower_limit="56.5" upper_limit="118"/>
                    <measurement group_id="O20" value="99.9" lower_limit="83.2" upper_limit="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="37"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5535" lower_limit="2947" upper_limit="10398"/>
                    <measurement group_id="O2" value="4795" lower_limit="2781" upper_limit="8267"/>
                    <measurement group_id="O3" value="126" lower_limit="96.5" upper_limit="164"/>
                    <measurement group_id="O4" value="727" lower_limit="297" upper_limit="1783"/>
                    <measurement group_id="O5" value="440" lower_limit="194" upper_limit="997"/>
                    <measurement group_id="O6" value="990" lower_limit="479" upper_limit="2045"/>
                    <measurement group_id="O7" value="468" lower_limit="254" upper_limit="862"/>
                    <measurement group_id="O8" value="255" lower_limit="101" upper_limit="646"/>
                    <measurement group_id="O9" value="76.1" lower_limit="69.0" upper_limit="83.9"/>
                    <measurement group_id="O10" value="210" lower_limit="93.6" upper_limit="471"/>
                    <measurement group_id="O11" value="187" lower_limit="93.3" upper_limit="374"/>
                    <measurement group_id="O12" value="225" lower_limit="115" upper_limit="441"/>
                    <measurement group_id="O13" value="325" lower_limit="139" upper_limit="762"/>
                    <measurement group_id="O14" value="93.9" lower_limit="78.5" upper_limit="112"/>
                    <measurement group_id="O15" value="110" lower_limit="92.3" upper_limit="131"/>
                    <measurement group_id="O16" value="89.6" lower_limit="75.5" upper_limit="106"/>
                    <measurement group_id="O17" value="82.7" lower_limit="71.8" upper_limit="95.3"/>
                    <measurement group_id="O18" value="60.9" lower_limit="55.5" upper_limit="66.8"/>
                    <measurement group_id="O19" value="60.9" lower_limit="55.5" upper_limit="66.8"/>
                    <measurement group_id="O20" value="96.3" lower_limit="84.2" upper_limit="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3184" lower_limit="2007" upper_limit="5052"/>
                    <measurement group_id="O2" value="3450" lower_limit="1685" upper_limit="7065"/>
                    <measurement group_id="O3" value="82.1" lower_limit="76.8" upper_limit="87.6"/>
                    <measurement group_id="O4" value="2545" lower_limit="1074" upper_limit="6028"/>
                    <measurement group_id="O5" value="2067" lower_limit="1190" upper_limit="3589"/>
                    <measurement group_id="O6" value="6417" lower_limit="2978" upper_limit="13829"/>
                    <measurement group_id="O7" value="1435" lower_limit="854" upper_limit="2411"/>
                    <measurement group_id="O8" value="2475" lower_limit="1135" upper_limit="5400"/>
                    <measurement group_id="O9" value="71.5" lower_limit="64.4" upper_limit="79.4"/>
                    <measurement group_id="O10" value="914" lower_limit="436" upper_limit="1914"/>
                    <measurement group_id="O11" value="1883" lower_limit="1106" upper_limit="3206"/>
                    <measurement group_id="O12" value="2242" lower_limit="973" upper_limit="5163"/>
                    <measurement group_id="O13" value="1584" lower_limit="534" upper_limit="4697"/>
                    <measurement group_id="O14" value="91.7" lower_limit="77.3" upper_limit="109"/>
                    <measurement group_id="O15" value="396" lower_limit="242" upper_limit="648"/>
                    <measurement group_id="O16" value="704" lower_limit="387" upper_limit="1283"/>
                    <measurement group_id="O17" value="506" lower_limit="299" upper_limit="856"/>
                    <measurement group_id="O18" value="771" lower_limit="326" upper_limit="1823"/>
                    <measurement group_id="O19" value="509" lower_limit="276" upper_limit="939"/>
                    <measurement group_id="O20" value="129" lower_limit="97.7" upper_limit="171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Fold Change of Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Response After Either Vaccine Dose, by Antigen</title>
        <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O10">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O15">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Fold Change of Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Response After Either Vaccine Dose, by Antigen</title>
          <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>fold change</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="49"/>
                <count group_id="O10" value="13"/>
                <count group_id="O11" value="15"/>
                <count group_id="O12" value="13"/>
                <count group_id="O13" value="13"/>
                <count group_id="O14" value="39"/>
                <count group_id="O15" value="30"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="24"/>
                <count group_id="O18" value="26"/>
                <count group_id="O19" value="29"/>
                <count group_id="O20" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" lower_limit="48.6" upper_limit="193"/>
                    <measurement group_id="O2" value="73.6" lower_limit="46.6" upper_limit="116"/>
                    <measurement group_id="O3" value="1.11" lower_limit="0.981" upper_limit="1.26"/>
                    <measurement group_id="O4" value="82.6" lower_limit="44.5" upper_limit="153"/>
                    <measurement group_id="O5" value="22.5" lower_limit="8.14" upper_limit="62.1"/>
                    <measurement group_id="O6" value="82.9" lower_limit="33.5" upper_limit="205"/>
                    <measurement group_id="O7" value="26.9" lower_limit="11.7" upper_limit="61.5"/>
                    <measurement group_id="O8" value="35.2" lower_limit="11.3" upper_limit="110"/>
                    <measurement group_id="O9" value="1.43" lower_limit="1.30" upper_limit="1.58"/>
                    <measurement group_id="O10" value="17.5" lower_limit="6.49" upper_limit="47.3"/>
                    <measurement group_id="O11" value="31.9" lower_limit="8.14" upper_limit="125"/>
                    <measurement group_id="O12" value="9.24" lower_limit="2.81" upper_limit="30.4"/>
                    <measurement group_id="O13" value="11.3" lower_limit="3.45" upper_limit="36.8"/>
                    <measurement group_id="O14" value="1.69" lower_limit="1.19" upper_limit="2.41"/>
                    <measurement group_id="O15" value="4.26" lower_limit="2.07" upper_limit="8.78"/>
                    <measurement group_id="O16" value="2.96" lower_limit="1.42" upper_limit="6.16"/>
                    <measurement group_id="O17" value="4.75" lower_limit="2.07" upper_limit="10.9"/>
                    <measurement group_id="O18" value="3.67" lower_limit="1.72" upper_limit="7.80"/>
                    <measurement group_id="O19" value="1.81" lower_limit="1.17" upper_limit="2.80"/>
                    <measurement group_id="O20" value="1.54" lower_limit="1.15" upper_limit="2.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.5" lower_limit="51.5" upper_limit="185"/>
                    <measurement group_id="O2" value="74.5" lower_limit="40.8" upper_limit="136"/>
                    <measurement group_id="O3" value="1.91" lower_limit="0.979" upper_limit="3.73"/>
                    <measurement group_id="O4" value="85.2" lower_limit="41.0" upper_limit="177"/>
                    <measurement group_id="O5" value="16.8" lower_limit="6.96" upper_limit="40.4"/>
                    <measurement group_id="O6" value="38.2" lower_limit="20.3" upper_limit="71.9"/>
                    <measurement group_id="O7" value="15.3" lower_limit="6.97" upper_limit="33.4"/>
                    <measurement group_id="O8" value="34" lower_limit="18.7" upper_limit="61.8"/>
                    <measurement group_id="O9" value="1.6" lower_limit="1.32" upper_limit="1.94"/>
                    <measurement group_id="O10" value="7.38" lower_limit="2.95" upper_limit="18.5"/>
                    <measurement group_id="O11" value="13.2" lower_limit="6.07" upper_limit="28.8"/>
                    <measurement group_id="O12" value="21.1" lower_limit="7.38" upper_limit="60.2"/>
                    <measurement group_id="O13" value="5.83" lower_limit="1.73" upper_limit="19.7"/>
                    <measurement group_id="O14" value="1.56" lower_limit="1.29" upper_limit="1.89"/>
                    <measurement group_id="O15" value="3.67" lower_limit="2.07" upper_limit="6.50"/>
                    <measurement group_id="O16" value="3.39" lower_limit="1.78" upper_limit="6.46"/>
                    <measurement group_id="O17" value="2.95" lower_limit="1.70" upper_limit="5.12"/>
                    <measurement group_id="O18" value="2.81" lower_limit="1.75" upper_limit="4.52"/>
                    <measurement group_id="O19" value="2.72" lower_limit="1.64" upper_limit="4.50"/>
                    <measurement group_id="O20" value="1.62" lower_limit="1.23" upper_limit="2.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.5" lower_limit="23.0" upper_limit="86.3"/>
                    <measurement group_id="O2" value="57.1" lower_limit="28.5" upper_limit="114"/>
                    <measurement group_id="O3" value="1.05" lower_limit="0.937" upper_limit="1.18"/>
                    <measurement group_id="O4" value="57.2" lower_limit="23.2" upper_limit="141"/>
                    <measurement group_id="O5" value="20.2" lower_limit="9.40" upper_limit="43.3"/>
                    <measurement group_id="O6" value="26.5" lower_limit="8.44" upper_limit="82.9"/>
                    <measurement group_id="O7" value="12.3" lower_limit="4.99" upper_limit="30.1"/>
                    <measurement group_id="O8" value="11.1" lower_limit="2.98" upper_limit="41.0"/>
                    <measurement group_id="O9" value="1.26" lower_limit="1.14" upper_limit="1.39"/>
                    <measurement group_id="O10" value="4.62" lower_limit="1.68" upper_limit="12.7"/>
                    <measurement group_id="O11" value="5.26" lower_limit="1.87" upper_limit="14.8"/>
                    <measurement group_id="O12" value="3.67" lower_limit="1.44" upper_limit="9.37"/>
                    <measurement group_id="O13" value="8.92" lower_limit="2.89" upper_limit="27.5"/>
                    <measurement group_id="O14" value="1.16" lower_limit="1.02" upper_limit="1.31"/>
                    <measurement group_id="O15" value="2.52" lower_limit="1.58" upper_limit="4.03"/>
                    <measurement group_id="O16" value="1.54" lower_limit="1.09" upper_limit="2.17"/>
                    <measurement group_id="O17" value="1.58" lower_limit="1.20" upper_limit="2.09"/>
                    <measurement group_id="O18" value="1.48" lower_limit="1.06" upper_limit="2.07"/>
                    <measurement group_id="O19" value="1.29" lower_limit="0.897" upper_limit="1.87"/>
                    <measurement group_id="O20" value="1.37" lower_limit="1.15" upper_limit="1.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="37"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.6" lower_limit="33.8" upper_limit="127"/>
                    <measurement group_id="O2" value="59.4" lower_limit="34.1" upper_limit="103"/>
                    <measurement group_id="O3" value="1.43" lower_limit="1.08" upper_limit="1.89"/>
                    <measurement group_id="O4" value="12.5" lower_limit="5.10" upper_limit="30.7"/>
                    <measurement group_id="O5" value="7.1" lower_limit="3.14" upper_limit="16.1"/>
                    <measurement group_id="O6" value="14.9" lower_limit="7.01" upper_limit="31.6"/>
                    <measurement group_id="O7" value="5.84" lower_limit="3.17" upper_limit="10.8"/>
                    <measurement group_id="O8" value="6" lower_limit="2.37" upper_limit="15.2"/>
                    <measurement group_id="O9" value="1.28" lower_limit="1.19" upper_limit="1.37"/>
                    <measurement group_id="O10" value="3.2" lower_limit="1.41" upper_limit="7.28"/>
                    <measurement group_id="O11" value="2.83" lower_limit="1.36" upper_limit="5.87"/>
                    <measurement group_id="O12" value="3.98" lower_limit="2.04" upper_limit="7.76"/>
                    <measurement group_id="O13" value="2.96" lower_limit="1.26" upper_limit="6.93"/>
                    <measurement group_id="O14" value="1.33" lower_limit="1.15" upper_limit="1.53"/>
                    <measurement group_id="O15" value="1.3" lower_limit="1.11" upper_limit="1.52"/>
                    <measurement group_id="O16" value="1.38" lower_limit="1.16" upper_limit="1.64"/>
                    <measurement group_id="O17" value="1.5" lower_limit="1.31" upper_limit="1.73"/>
                    <measurement group_id="O18" value="1.03" lower_limit="0.941" upper_limit="1.13"/>
                    <measurement group_id="O19" value="1.38" lower_limit="1.20" upper_limit="1.57"/>
                    <measurement group_id="O20" value="1.24" lower_limit="1.14" upper_limit="1.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="24"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.5" lower_limit="28.7" upper_limit="72.2"/>
                    <measurement group_id="O2" value="49.3" lower_limit="24.1" upper_limit="101"/>
                    <measurement group_id="O3" value="1.17" lower_limit="1.10" upper_limit="1.25"/>
                    <measurement group_id="O4" value="44.3" lower_limit="19.5" upper_limit="101"/>
                    <measurement group_id="O5" value="36.9" lower_limit="21.2" upper_limit="64.2"/>
                    <measurement group_id="O6" value="106" lower_limit="49.7" upper_limit="225"/>
                    <measurement group_id="O7" value="25" lower_limit="14.9" upper_limit="41.9"/>
                    <measurement group_id="O8" value="41.3" lower_limit="18.9" upper_limit="90.0"/>
                    <measurement group_id="O9" value="1.23" lower_limit="1.10" upper_limit="1.38"/>
                    <measurement group_id="O10" value="16" lower_limit="7.65" upper_limit="33.6"/>
                    <measurement group_id="O11" value="35.6" lower_limit="21.3" upper_limit="59.7"/>
                    <measurement group_id="O12" value="39" lower_limit="16.9" upper_limit="89.8"/>
                    <measurement group_id="O13" value="16.2" lower_limit="5.48" upper_limit="48.2"/>
                    <measurement group_id="O14" value="1.47" lower_limit="1.26" upper_limit="1.71"/>
                    <measurement group_id="O15" value="4.85" lower_limit="2.94" upper_limit="7.99"/>
                    <measurement group_id="O16" value="8.8" lower_limit="4.83" upper_limit="16.0"/>
                    <measurement group_id="O17" value="7.55" lower_limit="4.46" upper_limit="12.8"/>
                    <measurement group_id="O18" value="12.6" lower_limit="5.34" upper_limit="29.9"/>
                    <measurement group_id="O19" value="9.25" lower_limit="5.01" upper_limit="17.1"/>
                    <measurement group_id="O20" value="1.91" lower_limit="1.45" upper_limit="2.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of 6-11 Month Old Subjects With ≥Two-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response, by Antigen</title>
        <description>Fecal secretion was measured on Day 7, Day 19, and Day 28; number in table is subjects experiencing a two-fold rise at any of these time points. Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>28 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of 6-11 Month Old Subjects With ≥Two-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response, by Antigen</title>
          <description>Fecal secretion was measured on Day 7, Day 19, and Day 28; number in table is subjects experiencing a two-fold rise at any of these time points. Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of 6-11 Month Old Subjects With ≥Four-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response, by Antigen</title>
        <description>Fecal secretion was measured on Day 7, Day 19, and Day 28; number in table is subjects experiencing a four-fold rise at any of these time points. Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>28 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of 6-11 Month Old Subjects With ≥Four-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response, by Antigen</title>
          <description>Fecal secretion was measured on Day 7, Day 19, and Day 28; number in table is subjects experiencing a four-fold rise at any of these time points. Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Titer (GMT) of Fecal Secretory Immunoglobulin A (SIgA) Response 6-11 Month Old Subjects, by Antigen</title>
        <description>Fecal secretion was measured on Day 7, Day 19, and Day 28; number in table is based on the maximum value for each subject. Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>28 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Titer (GMT) of Fecal Secretory Immunoglobulin A (SIgA) Response 6-11 Month Old Subjects, by Antigen</title>
          <description>Fecal secretion was measured on Day 7, Day 19, and Day 28; number in table is based on the maximum value for each subject. Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.3" lower_limit="38.2" upper_limit="145"/>
                    <measurement group_id="O2" value="281" lower_limit="137" upper_limit="578"/>
                    <measurement group_id="O3" value="141" lower_limit="69.5" upper_limit="285"/>
                    <measurement group_id="O4" value="230" lower_limit="126" upper_limit="418"/>
                    <measurement group_id="O5" value="122" lower_limit="72.6" upper_limit="207"/>
                    <measurement group_id="O6" value="113" lower_limit="70.0" upper_limit="183"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="236" lower_limit="94.4" upper_limit="588"/>
                    <measurement group_id="O2" value="340" lower_limit="150" upper_limit="744"/>
                    <measurement group_id="O3" value="101" lower_limit="44" upper_limit="230"/>
                    <measurement group_id="O4" value="332" lower_limit="199" upper_limit="551"/>
                    <measurement group_id="O5" value="402" lower_limit="234" upper_limit="689"/>
                    <measurement group_id="O6" value="204" lower_limit="141" upper_limit="295"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.7" lower_limit="28.9" upper_limit="78.7"/>
                    <measurement group_id="O2" value="153" lower_limit="89.7" upper_limit="263"/>
                    <measurement group_id="O3" value="63.9" lower_limit="26.3" upper_limit="155"/>
                    <measurement group_id="O4" value="107" lower_limit="74.9" upper_limit="153"/>
                    <measurement group_id="O5" value="127" lower_limit="65.0" upper_limit="249"/>
                    <measurement group_id="O6" value="74" lower_limit="49.2" upper_limit="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122" lower_limit="65.9" upper_limit="226"/>
                    <measurement group_id="O2" value="272" lower_limit="152" upper_limit="488"/>
                    <measurement group_id="O3" value="90.3" lower_limit="46.5" upper_limit="175"/>
                    <measurement group_id="O4" value="361" lower_limit="199" upper_limit="656"/>
                    <measurement group_id="O5" value="170" lower_limit="102" upper_limit="281"/>
                    <measurement group_id="O6" value="181" lower_limit="114" upper_limit="287"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="655" lower_limit="397" upper_limit="1079"/>
                    <measurement group_id="O2" value="2330" lower_limit="1140" upper_limit="4764"/>
                    <measurement group_id="O3" value="1500" lower_limit="838" upper_limit="2684"/>
                    <measurement group_id="O4" value="4159" lower_limit="1995" upper_limit="8672"/>
                    <measurement group_id="O5" value="1299" lower_limit="600" upper_limit="2813"/>
                    <measurement group_id="O6" value="839" lower_limit="549" upper_limit="1281"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Fold Change of Fecal Secretory Immunoglobulin A (SIgA) Response Among 6-11 Month Old Subjects, by Antigen</title>
        <description>Fecal secretion was measured on Day 7, Day 19, and Day 28; number in table is based on the maximum value for each subject. Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>28 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Fold Change of Fecal Secretory Immunoglobulin A (SIgA) Response Among 6-11 Month Old Subjects, by Antigen</title>
          <description>Fecal secretion was measured on Day 7, Day 19, and Day 28; number in table is based on the maximum value for each subject. Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>fold change</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.59" lower_limit="2.19" upper_limit="5.90"/>
                    <measurement group_id="O2" value="3.36" lower_limit="1.60" upper_limit="7.05"/>
                    <measurement group_id="O3" value="3.41" lower_limit="1.31" upper_limit="8.90"/>
                    <measurement group_id="O4" value="5.19" lower_limit="2.37" upper_limit="11.4"/>
                    <measurement group_id="O5" value="2.7" lower_limit="1.28" upper_limit="5.73"/>
                    <measurement group_id="O6" value="2.1" lower_limit="1.21" upper_limit="3.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.98" lower_limit="1.80" upper_limit="4.92"/>
                    <measurement group_id="O2" value="2.57" lower_limit="1.32" upper_limit="5.00"/>
                    <measurement group_id="O3" value="2" lower_limit="0.743" upper_limit="5.38"/>
                    <measurement group_id="O4" value="4.6" lower_limit="2.18" upper_limit="9.74"/>
                    <measurement group_id="O5" value="3.66" lower_limit="2.22" upper_limit="6.02"/>
                    <measurement group_id="O6" value="1.91" lower_limit="1.28" upper_limit="2.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.47" lower_limit="1.50" upper_limit="4.07"/>
                    <measurement group_id="O2" value="2.63" lower_limit="1.42" upper_limit="4.85"/>
                    <measurement group_id="O3" value="3.96" lower_limit="1.41" upper_limit="11.1"/>
                    <measurement group_id="O4" value="4.08" lower_limit="2.14" upper_limit="7.77"/>
                    <measurement group_id="O5" value="1.78" lower_limit="1.03" upper_limit="3.06"/>
                    <measurement group_id="O6" value="1.79" lower_limit="1.12" upper_limit="2.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.76" lower_limit="0.937" upper_limit="3.30"/>
                    <measurement group_id="O2" value="2.85" lower_limit="1.53" upper_limit="5.31"/>
                    <measurement group_id="O3" value="1.4" lower_limit="0.362" upper_limit="5.40"/>
                    <measurement group_id="O4" value="7.21" lower_limit="3.44" upper_limit="15.1"/>
                    <measurement group_id="O5" value="1.72" lower_limit="1.08" upper_limit="2.73"/>
                    <measurement group_id="O6" value="1.96" lower_limit="1.21" upper_limit="3.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.74" lower_limit="1.82" upper_limit="7.68"/>
                    <measurement group_id="O2" value="3.71" lower_limit="2.01" upper_limit="6.87"/>
                    <measurement group_id="O3" value="8.3" lower_limit="4.18" upper_limit="16.5"/>
                    <measurement group_id="O4" value="8.8" lower_limit="3.73" upper_limit="20.8"/>
                    <measurement group_id="O5" value="5.64" lower_limit="2.31" upper_limit="13.8"/>
                    <measurement group_id="O6" value="2.58" lower_limit="1.52" upper_limit="4.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of Subjects With ≥Two-fold Increase in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for Antigens in ETVAX</title>
        <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O10">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O15">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of Subjects With ≥Two-fold Increase in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for Antigens in ETVAX</title>
          <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="49"/>
                <count group_id="O10" value="13"/>
                <count group_id="O11" value="15"/>
                <count group_id="O12" value="13"/>
                <count group_id="O13" value="13"/>
                <count group_id="O14" value="39"/>
                <count group_id="O15" value="30"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="26"/>
                <count group_id="O19" value="29"/>
                <count group_id="O20" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="12"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="7"/>
                    <measurement group_id="O11" value="11"/>
                    <measurement group_id="O12" value="5"/>
                    <measurement group_id="O13" value="8"/>
                    <measurement group_id="O14" value="8"/>
                    <measurement group_id="O15" value="12"/>
                    <measurement group_id="O16" value="14"/>
                    <measurement group_id="O17" value="11"/>
                    <measurement group_id="O18" value="12"/>
                    <measurement group_id="O19" value="14"/>
                    <measurement group_id="O20" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="46"/>
                    <measurement group_id="O10" value="6"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="8"/>
                    <measurement group_id="O13" value="5"/>
                    <measurement group_id="O14" value="31"/>
                    <measurement group_id="O15" value="18"/>
                    <measurement group_id="O16" value="16"/>
                    <measurement group_id="O17" value="14"/>
                    <measurement group_id="O18" value="14"/>
                    <measurement group_id="O19" value="15"/>
                    <measurement group_id="O20" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="10"/>
                    <measurement group_id="O8" value="13"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="7"/>
                    <measurement group_id="O11" value="6"/>
                    <measurement group_id="O12" value="5"/>
                    <measurement group_id="O13" value="6"/>
                    <measurement group_id="O14" value="8"/>
                    <measurement group_id="O15" value="15"/>
                    <measurement group_id="O16" value="17"/>
                    <measurement group_id="O17" value="13"/>
                    <measurement group_id="O18" value="12"/>
                    <measurement group_id="O19" value="14"/>
                    <measurement group_id="O20" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="44"/>
                    <measurement group_id="O10" value="6"/>
                    <measurement group_id="O11" value="9"/>
                    <measurement group_id="O12" value="8"/>
                    <measurement group_id="O13" value="7"/>
                    <measurement group_id="O14" value="31"/>
                    <measurement group_id="O15" value="15"/>
                    <measurement group_id="O16" value="13"/>
                    <measurement group_id="O17" value="12"/>
                    <measurement group_id="O18" value="14"/>
                    <measurement group_id="O19" value="15"/>
                    <measurement group_id="O20" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="8"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="5"/>
                    <measurement group_id="O11" value="5"/>
                    <measurement group_id="O12" value="3"/>
                    <measurement group_id="O13" value="7"/>
                    <measurement group_id="O14" value="7"/>
                    <measurement group_id="O15" value="10"/>
                    <measurement group_id="O16" value="13"/>
                    <measurement group_id="O17" value="10"/>
                    <measurement group_id="O18" value="13"/>
                    <measurement group_id="O19" value="9"/>
                    <measurement group_id="O20" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="8"/>
                    <measurement group_id="O8" value="7"/>
                    <measurement group_id="O9" value="46"/>
                    <measurement group_id="O10" value="8"/>
                    <measurement group_id="O11" value="10"/>
                    <measurement group_id="O12" value="10"/>
                    <measurement group_id="O13" value="6"/>
                    <measurement group_id="O14" value="32"/>
                    <measurement group_id="O15" value="20"/>
                    <measurement group_id="O16" value="17"/>
                    <measurement group_id="O17" value="15"/>
                    <measurement group_id="O18" value="13"/>
                    <measurement group_id="O19" value="20"/>
                    <measurement group_id="O20" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="8"/>
                    <measurement group_id="O8" value="5"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="6"/>
                    <measurement group_id="O11" value="5"/>
                    <measurement group_id="O12" value="3"/>
                    <measurement group_id="O13" value="5"/>
                    <measurement group_id="O14" value="6"/>
                    <measurement group_id="O15" value="11"/>
                    <measurement group_id="O16" value="9"/>
                    <measurement group_id="O17" value="9"/>
                    <measurement group_id="O18" value="11"/>
                    <measurement group_id="O19" value="12"/>
                    <measurement group_id="O20" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="10"/>
                    <measurement group_id="O9" value="46"/>
                    <measurement group_id="O10" value="7"/>
                    <measurement group_id="O11" value="10"/>
                    <measurement group_id="O12" value="10"/>
                    <measurement group_id="O13" value="8"/>
                    <measurement group_id="O14" value="33"/>
                    <measurement group_id="O15" value="19"/>
                    <measurement group_id="O16" value="21"/>
                    <measurement group_id="O17" value="16"/>
                    <measurement group_id="O18" value="15"/>
                    <measurement group_id="O19" value="17"/>
                    <measurement group_id="O20" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="15"/>
                    <measurement group_id="O7" value="14"/>
                    <measurement group_id="O8" value="14"/>
                    <measurement group_id="O9" value="9"/>
                    <measurement group_id="O10" value="12"/>
                    <measurement group_id="O11" value="12"/>
                    <measurement group_id="O12" value="12"/>
                    <measurement group_id="O13" value="13"/>
                    <measurement group_id="O14" value="8"/>
                    <measurement group_id="O15" value="22"/>
                    <measurement group_id="O16" value="26"/>
                    <measurement group_id="O17" value="21"/>
                    <measurement group_id="O18" value="21"/>
                    <measurement group_id="O19" value="24"/>
                    <measurement group_id="O20" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="40"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="31"/>
                    <measurement group_id="O15" value="8"/>
                    <measurement group_id="O16" value="4"/>
                    <measurement group_id="O17" value="4"/>
                    <measurement group_id="O18" value="5"/>
                    <measurement group_id="O19" value="5"/>
                    <measurement group_id="O20" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of Subjects With ≥Four-fold Increase in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for Antigens in ETVAX</title>
        <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O10">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O15">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of Subjects With ≥Four-fold Increase in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for Antigens in ETVAX</title>
          <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="49"/>
                <count group_id="O10" value="13"/>
                <count group_id="O11" value="15"/>
                <count group_id="O12" value="13"/>
                <count group_id="O13" value="13"/>
                <count group_id="O14" value="39"/>
                <count group_id="O15" value="30"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="26"/>
                <count group_id="O19" value="29"/>
                <count group_id="O20" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="10"/>
                    <measurement group_id="O8" value="11"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="3"/>
                    <measurement group_id="O13" value="4"/>
                    <measurement group_id="O14" value="4"/>
                    <measurement group_id="O15" value="9"/>
                    <measurement group_id="O16" value="9"/>
                    <measurement group_id="O17" value="6"/>
                    <measurement group_id="O18" value="9"/>
                    <measurement group_id="O19" value="7"/>
                    <measurement group_id="O20" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="47"/>
                    <measurement group_id="O10" value="10"/>
                    <measurement group_id="O11" value="11"/>
                    <measurement group_id="O12" value="10"/>
                    <measurement group_id="O13" value="9"/>
                    <measurement group_id="O14" value="35"/>
                    <measurement group_id="O15" value="21"/>
                    <measurement group_id="O16" value="21"/>
                    <measurement group_id="O17" value="19"/>
                    <measurement group_id="O18" value="17"/>
                    <measurement group_id="O19" value="22"/>
                    <measurement group_id="O20" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="7"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="5"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="4"/>
                    <measurement group_id="O13" value="4"/>
                    <measurement group_id="O14" value="4"/>
                    <measurement group_id="O15" value="8"/>
                    <measurement group_id="O16" value="10"/>
                    <measurement group_id="O17" value="7"/>
                    <measurement group_id="O18" value="5"/>
                    <measurement group_id="O19" value="10"/>
                    <measurement group_id="O20" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="8"/>
                    <measurement group_id="O9" value="48"/>
                    <measurement group_id="O10" value="8"/>
                    <measurement group_id="O11" value="12"/>
                    <measurement group_id="O12" value="9"/>
                    <measurement group_id="O13" value="9"/>
                    <measurement group_id="O14" value="35"/>
                    <measurement group_id="O15" value="22"/>
                    <measurement group_id="O16" value="20"/>
                    <measurement group_id="O17" value="18"/>
                    <measurement group_id="O18" value="21"/>
                    <measurement group_id="O19" value="19"/>
                    <measurement group_id="O20" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="2"/>
                    <measurement group_id="O13" value="2"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="3"/>
                    <measurement group_id="O16" value="8"/>
                    <measurement group_id="O17" value="5"/>
                    <measurement group_id="O18" value="7"/>
                    <measurement group_id="O19" value="6"/>
                    <measurement group_id="O20" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="11"/>
                    <measurement group_id="O9" value="49"/>
                    <measurement group_id="O10" value="11"/>
                    <measurement group_id="O11" value="12"/>
                    <measurement group_id="O12" value="11"/>
                    <measurement group_id="O13" value="11"/>
                    <measurement group_id="O14" value="37"/>
                    <measurement group_id="O15" value="27"/>
                    <measurement group_id="O16" value="22"/>
                    <measurement group_id="O17" value="20"/>
                    <measurement group_id="O18" value="19"/>
                    <measurement group_id="O19" value="23"/>
                    <measurement group_id="O20" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="4"/>
                    <measurement group_id="O15" value="4"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="4"/>
                    <measurement group_id="O18" value="7"/>
                    <measurement group_id="O19" value="5"/>
                    <measurement group_id="O20" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="13"/>
                    <measurement group_id="O9" value="48"/>
                    <measurement group_id="O10" value="10"/>
                    <measurement group_id="O11" value="14"/>
                    <measurement group_id="O12" value="12"/>
                    <measurement group_id="O13" value="10"/>
                    <measurement group_id="O14" value="35"/>
                    <measurement group_id="O15" value="26"/>
                    <measurement group_id="O16" value="28"/>
                    <measurement group_id="O17" value="21"/>
                    <measurement group_id="O18" value="19"/>
                    <measurement group_id="O19" value="24"/>
                    <measurement group_id="O20" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="14"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="14"/>
                    <measurement group_id="O9" value="6"/>
                    <measurement group_id="O10" value="9"/>
                    <measurement group_id="O11" value="11"/>
                    <measurement group_id="O12" value="10"/>
                    <measurement group_id="O13" value="13"/>
                    <measurement group_id="O14" value="4"/>
                    <measurement group_id="O15" value="17"/>
                    <measurement group_id="O16" value="21"/>
                    <measurement group_id="O17" value="17"/>
                    <measurement group_id="O18" value="18"/>
                    <measurement group_id="O19" value="22"/>
                    <measurement group_id="O20" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="43"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="3"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="35"/>
                    <measurement group_id="O15" value="13"/>
                    <measurement group_id="O16" value="9"/>
                    <measurement group_id="O17" value="8"/>
                    <measurement group_id="O18" value="8"/>
                    <measurement group_id="O19" value="7"/>
                    <measurement group_id="O20" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Titer (GMT) of Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for Antigens in ETVAX</title>
        <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O10">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O15">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Titer (GMT) of Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for Antigens in ETVAX</title>
          <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="49"/>
                <count group_id="O10" value="13"/>
                <count group_id="O11" value="15"/>
                <count group_id="O12" value="13"/>
                <count group_id="O13" value="13"/>
                <count group_id="O14" value="39"/>
                <count group_id="O15" value="30"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="26"/>
                <count group_id="O19" value="29"/>
                <count group_id="O20" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.4" lower_limit="48.9" upper_limit="113"/>
                    <measurement group_id="O2" value="57.8" lower_limit="39.6" upper_limit="94.4"/>
                    <measurement group_id="O3" value="20" lower_limit="17.4" upper_limit="23.0"/>
                    <measurement group_id="O4" value="665" lower_limit="392" upper_limit="1127"/>
                    <measurement group_id="O5" value="692" lower_limit="414" upper_limit="1158"/>
                    <measurement group_id="O6" value="1036" lower_limit="569" upper_limit="1887"/>
                    <measurement group_id="O7" value="669" lower_limit="330" upper_limit="1356"/>
                    <measurement group_id="O8" value="677" lower_limit="269" upper_limit="1705"/>
                    <measurement group_id="O9" value="265" lower_limit="223" upper_limit="315"/>
                    <measurement group_id="O10" value="368" lower_limit="148" upper_limit="919"/>
                    <measurement group_id="O11" value="532" lower_limit="224" upper_limit="1263"/>
                    <measurement group_id="O12" value="163" lower_limit="80.1" upper_limit="334"/>
                    <measurement group_id="O13" value="189" lower_limit="72.0" upper_limit="496"/>
                    <measurement group_id="O14" value="115" lower_limit="81.9" upper_limit="162"/>
                    <measurement group_id="O15" value="111" lower_limit="64" upper_limit="192"/>
                    <measurement group_id="O16" value="133" lower_limit="66.3" upper_limit="267"/>
                    <measurement group_id="O17" value="164" lower_limit="83.3" upper_limit="322"/>
                    <measurement group_id="O18" value="63.4" lower_limit="28.8" upper_limit="140"/>
                    <measurement group_id="O19" value="98.4" lower_limit="65.8" upper_limit="147"/>
                    <measurement group_id="O20" value="59.2" lower_limit="43.2" upper_limit="81.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="243" lower_limit="162" upper_limit="363"/>
                    <measurement group_id="O2" value="229" lower_limit="153" upper_limit="344"/>
                    <measurement group_id="O3" value="53.1" lower_limit="31.1" upper_limit="90.6"/>
                    <measurement group_id="O4" value="991" lower_limit="684" upper_limit="1437"/>
                    <measurement group_id="O5" value="529" lower_limit="222" upper_limit="1260"/>
                    <measurement group_id="O6" value="475" lower_limit="315" upper_limit="718"/>
                    <measurement group_id="O7" value="483" lower_limit="309" upper_limit="754"/>
                    <measurement group_id="O8" value="1299" lower_limit="752" upper_limit="2244"/>
                    <measurement group_id="O9" value="237" lower_limit="189" upper_limit="297"/>
                    <measurement group_id="O10" value="318" lower_limit="132" upper_limit="768"/>
                    <measurement group_id="O11" value="590" lower_limit="384" upper_limit="907"/>
                    <measurement group_id="O12" value="245" lower_limit="115" upper_limit="526"/>
                    <measurement group_id="O13" value="260" lower_limit="103" upper_limit="656"/>
                    <measurement group_id="O14" value="141" lower_limit="100" upper_limit="197"/>
                    <measurement group_id="O15" value="105" lower_limit="61.2" upper_limit="181"/>
                    <measurement group_id="O16" value="140" lower_limit="80.8" upper_limit="242"/>
                    <measurement group_id="O17" value="77.6" lower_limit="46.5" upper_limit="130"/>
                    <measurement group_id="O18" value="45.1" lower_limit="30.1" upper_limit="67.6"/>
                    <measurement group_id="O19" value="111" lower_limit="74.0" upper_limit="167"/>
                    <measurement group_id="O20" value="53.8" lower_limit="39.9" upper_limit="72.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.3" lower_limit="21.7" upper_limit="57.4"/>
                    <measurement group_id="O2" value="42.1" lower_limit="28.9" upper_limit="61.3"/>
                    <measurement group_id="O3" value="13.6" lower_limit="9.92" upper_limit="18.7"/>
                    <measurement group_id="O4" value="147" lower_limit="87.9" upper_limit="247"/>
                    <measurement group_id="O5" value="131" lower_limit="65.2" upper_limit="263"/>
                    <measurement group_id="O6" value="402" lower_limit="290" upper_limit="558"/>
                    <measurement group_id="O7" value="317" lower_limit="225" upper_limit="447"/>
                    <measurement group_id="O8" value="194" lower_limit="111" upper_limit="339"/>
                    <measurement group_id="O9" value="123" lower_limit="91.7" upper_limit="166"/>
                    <measurement group_id="O10" value="76.1" lower_limit="37.2" upper_limit="156"/>
                    <measurement group_id="O11" value="191" lower_limit="132" upper_limit="277"/>
                    <measurement group_id="O12" value="298" lower_limit="219" upper_limit="405"/>
                    <measurement group_id="O13" value="203" lower_limit="136" upper_limit="305"/>
                    <measurement group_id="O14" value="96.6" lower_limit="67.3" upper_limit="139"/>
                    <measurement group_id="O15" value="67.3" lower_limit="46.4" upper_limit="97.6"/>
                    <measurement group_id="O16" value="78.9" lower_limit="53.3" upper_limit="117"/>
                    <measurement group_id="O17" value="67" lower_limit="43.6" upper_limit="103"/>
                    <measurement group_id="O18" value="57.2" lower_limit="37.4" upper_limit="87.5"/>
                    <measurement group_id="O19" value="129" lower_limit="94.7" upper_limit="176"/>
                    <measurement group_id="O20" value="58.9" lower_limit="43.5" upper_limit="79.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.8" lower_limit="55.9" upper_limit="129"/>
                    <measurement group_id="O2" value="72.1" lower_limit="42.1" upper_limit="123"/>
                    <measurement group_id="O3" value="20.7" lower_limit="14.4" upper_limit="29.8"/>
                    <measurement group_id="O4" value="531" lower_limit="304" upper_limit="926"/>
                    <measurement group_id="O5" value="694" lower_limit="416" upper_limit="1157"/>
                    <measurement group_id="O6" value="508" lower_limit="286" upper_limit="904"/>
                    <measurement group_id="O7" value="424" lower_limit="253" upper_limit="713"/>
                    <measurement group_id="O8" value="450" lower_limit="272" upper_limit="747"/>
                    <measurement group_id="O9" value="371" lower_limit="304" upper_limit="453"/>
                    <measurement group_id="O10" value="430" lower_limit="241" upper_limit="770"/>
                    <measurement group_id="O11" value="269" lower_limit="163" upper_limit="444"/>
                    <measurement group_id="O12" value="230" lower_limit="144" upper_limit="369"/>
                    <measurement group_id="O13" value="297" lower_limit="156" upper_limit="565"/>
                    <measurement group_id="O14" value="231" lower_limit="162" upper_limit="328"/>
                    <measurement group_id="O15" value="110" lower_limit="81.2" upper_limit="150"/>
                    <measurement group_id="O16" value="137" lower_limit="91.5" upper_limit="206"/>
                    <measurement group_id="O17" value="162" lower_limit="115" upper_limit="228"/>
                    <measurement group_id="O18" value="74" lower_limit="46.6" upper_limit="118"/>
                    <measurement group_id="O19" value="124" lower_limit="98.0" upper_limit="156"/>
                    <measurement group_id="O20" value="93.8" lower_limit="71.7" upper_limit="123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="277" lower_limit="190" upper_limit="404"/>
                    <measurement group_id="O2" value="390" lower_limit="180" upper_limit="842"/>
                    <measurement group_id="O3" value="10.1" lower_limit="6.01" upper_limit="16.9"/>
                    <measurement group_id="O4" value="791" lower_limit="455" upper_limit="1374"/>
                    <measurement group_id="O5" value="940" lower_limit="515" upper_limit="1715"/>
                    <measurement group_id="O6" value="568" lower_limit="364" upper_limit="887"/>
                    <measurement group_id="O7" value="386" lower_limit="209" upper_limit="715"/>
                    <measurement group_id="O8" value="469" lower_limit="260" upper_limit="847"/>
                    <measurement group_id="O9" value="67.3" lower_limit="50.0" upper_limit="90.6"/>
                    <measurement group_id="O10" value="518" lower_limit="188" upper_limit="1425"/>
                    <measurement group_id="O11" value="352" lower_limit="260" upper_limit="476"/>
                    <measurement group_id="O12" value="915" lower_limit="458" upper_limit="1830"/>
                    <measurement group_id="O13" value="1439" lower_limit="882" upper_limit="2347"/>
                    <measurement group_id="O14" value="89.3" lower_limit="66.0" upper_limit="121"/>
                    <measurement group_id="O15" value="253" lower_limit="131" upper_limit="489"/>
                    <measurement group_id="O16" value="1165" lower_limit="699" upper_limit="1941"/>
                    <measurement group_id="O17" value="723" lower_limit="390" upper_limit="1342"/>
                    <measurement group_id="O18" value="442" lower_limit="199" upper_limit="983"/>
                    <measurement group_id="O19" value="403" lower_limit="195" upper_limit="834"/>
                    <measurement group_id="O20" value="90.8" lower_limit="58.9" upper_limit="140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Fold Change in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for Antigens in ETVAX</title>
        <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O10">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O15">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Fold Change in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for Antigens in ETVAX</title>
          <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>fold change</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="49"/>
                <count group_id="O10" value="13"/>
                <count group_id="O11" value="15"/>
                <count group_id="O12" value="13"/>
                <count group_id="O13" value="13"/>
                <count group_id="O14" value="39"/>
                <count group_id="O15" value="30"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="26"/>
                <count group_id="O19" value="29"/>
                <count group_id="O20" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.34" lower_limit="2.34" upper_limit="4.77"/>
                    <measurement group_id="O2" value="3.46" lower_limit="2.44" upper_limit="4.90"/>
                    <measurement group_id="O3" value="1.2" lower_limit="1.06" upper_limit="1.36"/>
                    <measurement group_id="O4" value="2.92" lower_limit="2.01" upper_limit="4.25"/>
                    <measurement group_id="O5" value="3.52" lower_limit="2.28" upper_limit="5.44"/>
                    <measurement group_id="O6" value="3.21" lower_limit="1.87" upper_limit="5.50"/>
                    <measurement group_id="O7" value="5.65" lower_limit="3.02" upper_limit="10.6"/>
                    <measurement group_id="O8" value="6.84" lower_limit="2.69" upper_limit="17.4"/>
                    <measurement group_id="O9" value="1.19" lower_limit="1.04" upper_limit="1.37"/>
                    <measurement group_id="O10" value="2.4" lower_limit="1.47" upper_limit="3.92"/>
                    <measurement group_id="O11" value="2.59" lower_limit="1.49" upper_limit="4.51"/>
                    <measurement group_id="O12" value="1.68" lower_limit="0.741" upper_limit="3.80"/>
                    <measurement group_id="O13" value="2.94" lower_limit="1.60" upper_limit="5.41"/>
                    <measurement group_id="O14" value="1.28" lower_limit="0.992" upper_limit="1.65"/>
                    <measurement group_id="O15" value="2.02" lower_limit="1.30" upper_limit="3.15"/>
                    <measurement group_id="O16" value="2.2" lower_limit="1.43" upper_limit="3.40"/>
                    <measurement group_id="O17" value="1.96" lower_limit="1.27" upper_limit="3.02"/>
                    <measurement group_id="O18" value="3.08" lower_limit="1.59" upper_limit="6.00"/>
                    <measurement group_id="O19" value="1.81" lower_limit="1.30" upper_limit="2.53"/>
                    <measurement group_id="O20" value="1.62" lower_limit="1.25" upper_limit="2.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.54" lower_limit="4.72" upper_limit="15.5"/>
                    <measurement group_id="O2" value="7.43" lower_limit="4.09" upper_limit="13.5"/>
                    <measurement group_id="O3" value="1.62" lower_limit="1.16" upper_limit="2.25"/>
                    <measurement group_id="O4" value="5.42" lower_limit="3.94" upper_limit="7.46"/>
                    <measurement group_id="O5" value="6" lower_limit="2.82" upper_limit="12.8"/>
                    <measurement group_id="O6" value="3.87" lower_limit="2.44" upper_limit="6.13"/>
                    <measurement group_id="O7" value="3.16" lower_limit="1.79" upper_limit="5.56"/>
                    <measurement group_id="O8" value="4.3" lower_limit="2.34" upper_limit="7.90"/>
                    <measurement group_id="O9" value="1.17" lower_limit="1.00" upper_limit="1.36"/>
                    <measurement group_id="O10" value="2.56" lower_limit="1.07" upper_limit="6.09"/>
                    <measurement group_id="O11" value="1.96" lower_limit="1.30" upper_limit="2.98"/>
                    <measurement group_id="O12" value="2.15" lower_limit="0.881" upper_limit="5.26"/>
                    <measurement group_id="O13" value="2.82" lower_limit="1.21" upper_limit="6.60"/>
                    <measurement group_id="O14" value="1.25" lower_limit="0.937" upper_limit="1.66"/>
                    <measurement group_id="O15" value="2.33" lower_limit="1.57" upper_limit="3.47"/>
                    <measurement group_id="O16" value="2.54" lower_limit="1.70" upper_limit="3.78"/>
                    <measurement group_id="O17" value="2.24" lower_limit="1.52" upper_limit="3.31"/>
                    <measurement group_id="O18" value="2.06" lower_limit="1.46" upper_limit="2.93"/>
                    <measurement group_id="O19" value="2.93" lower_limit="1.80" upper_limit="4.77"/>
                    <measurement group_id="O20" value="1.53" lower_limit="1.20" upper_limit="1.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.75" lower_limit="1.80" upper_limit="4.21"/>
                    <measurement group_id="O2" value="3.11" lower_limit="2.20" upper_limit="4.41"/>
                    <measurement group_id="O3" value="1.03" lower_limit="0.759" upper_limit="1.39"/>
                    <measurement group_id="O4" value="2.81" lower_limit="1.87" upper_limit="4.24"/>
                    <measurement group_id="O5" value="3.11" lower_limit="1.73" upper_limit="5.60"/>
                    <measurement group_id="O6" value="2.21" lower_limit="1.48" upper_limit="3.31"/>
                    <measurement group_id="O7" value="1.62" lower_limit="1.18" upper_limit="2.23"/>
                    <measurement group_id="O8" value="2.38" lower_limit="1.29" upper_limit="4.37"/>
                    <measurement group_id="O9" value="1.12" lower_limit="0.981" upper_limit="1.28"/>
                    <measurement group_id="O10" value="1.37" lower_limit="0.650" upper_limit="2.87"/>
                    <measurement group_id="O11" value="1.73" lower_limit="1.08" upper_limit="2.76"/>
                    <measurement group_id="O12" value="1.51" lower_limit="0.999" upper_limit="2.28"/>
                    <measurement group_id="O13" value="2.28" lower_limit="1.37" upper_limit="3.81"/>
                    <measurement group_id="O14" value="1.25" lower_limit="0.967" upper_limit="1.60"/>
                    <measurement group_id="O15" value="1.54" lower_limit="1.11" upper_limit="2.14"/>
                    <measurement group_id="O16" value="1.73" lower_limit="1.21" upper_limit="2.48"/>
                    <measurement group_id="O17" value="1.55" lower_limit="0.989" upper_limit="2.44"/>
                    <measurement group_id="O18" value="2.4" lower_limit="1.55" upper_limit="3.72"/>
                    <measurement group_id="O19" value="1.83" lower_limit="1.40" upper_limit="2.40"/>
                    <measurement group_id="O20" value="1.47" lower_limit="1.15" upper_limit="1.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.98" lower_limit="1.55" upper_limit="5.73"/>
                    <measurement group_id="O2" value="3.57" lower_limit="2.20" upper_limit="5.81"/>
                    <measurement group_id="O3" value="1.23" lower_limit="1.10" upper_limit="1.37"/>
                    <measurement group_id="O4" value="1.87" lower_limit="1.13" upper_limit="3.09"/>
                    <measurement group_id="O5" value="3.12" lower_limit="2.24" upper_limit="4.34"/>
                    <measurement group_id="O6" value="2.93" lower_limit="1.80" upper_limit="4.77"/>
                    <measurement group_id="O7" value="1.92" lower_limit="1.35" upper_limit="2.74"/>
                    <measurement group_id="O8" value="1.77" lower_limit="1.18" upper_limit="2.65"/>
                    <measurement group_id="O9" value="1.23" lower_limit="1.06" upper_limit="1.42"/>
                    <measurement group_id="O10" value="2.02" lower_limit="1.25" upper_limit="3.29"/>
                    <measurement group_id="O11" value="1.62" lower_limit="1.14" upper_limit="2.30"/>
                    <measurement group_id="O12" value="1.44" lower_limit="1.04" upper_limit="2.00"/>
                    <measurement group_id="O13" value="2.17" lower_limit="1.38" upper_limit="3.42"/>
                    <measurement group_id="O14" value="1.28" lower_limit="0.898" upper_limit="1.84"/>
                    <measurement group_id="O15" value="1.5" lower_limit="1.06" upper_limit="2.10"/>
                    <measurement group_id="O16" value="1.43" lower_limit="1.08" upper_limit="1.91"/>
                    <measurement group_id="O17" value="1.66" lower_limit="1.22" upper_limit="2.26"/>
                    <measurement group_id="O18" value="2.08" lower_limit="1.37" upper_limit="3.16"/>
                    <measurement group_id="O19" value="1.84" lower_limit="1.38" upper_limit="2.43"/>
                    <measurement group_id="O20" value="1.51" lower_limit="1.20" upper_limit="1.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="15"/>
                    <count group_id="O8" value="15"/>
                    <count group_id="O9" value="49"/>
                    <count group_id="O10" value="13"/>
                    <count group_id="O11" value="15"/>
                    <count group_id="O12" value="13"/>
                    <count group_id="O13" value="13"/>
                    <count group_id="O14" value="39"/>
                    <count group_id="O15" value="30"/>
                    <count group_id="O16" value="30"/>
                    <count group_id="O17" value="25"/>
                    <count group_id="O18" value="26"/>
                    <count group_id="O19" value="29"/>
                    <count group_id="O20" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="9.70" upper_limit="41.1"/>
                    <measurement group_id="O2" value="36" lower_limit="14.9" upper_limit="87.1"/>
                    <measurement group_id="O3" value="0.994" lower_limit="0.789" upper_limit="1.25"/>
                    <measurement group_id="O4" value="6.49" lower_limit="4.00" upper_limit="10.5"/>
                    <measurement group_id="O5" value="20.2" lower_limit="11.5" upper_limit="35.4"/>
                    <measurement group_id="O6" value="12.7" lower_limit="8.59" upper_limit="18.8"/>
                    <measurement group_id="O7" value="9.6" lower_limit="5.02" upper_limit="18.4"/>
                    <measurement group_id="O8" value="15.3" lower_limit="7.22" upper_limit="32.6"/>
                    <measurement group_id="O9" value="1.41" lower_limit="1.08" upper_limit="1.85"/>
                    <measurement group_id="O10" value="10.7" lower_limit="3.90" upper_limit="29.4"/>
                    <measurement group_id="O11" value="5.68" lower_limit="2.62" upper_limit="12.3"/>
                    <measurement group_id="O12" value="9.43" lower_limit="4.32" upper_limit="20.6"/>
                    <measurement group_id="O13" value="34.8" lower_limit="20.3" upper_limit="59.5"/>
                    <measurement group_id="O14" value="1.12" lower_limit="0.811" upper_limit="1.53"/>
                    <measurement group_id="O15" value="5.66" lower_limit="3.18" upper_limit="10.1"/>
                    <measurement group_id="O16" value="9.09" lower_limit="5.28" upper_limit="15.7"/>
                    <measurement group_id="O17" value="11.6" lower_limit="5.69" upper_limit="23.6"/>
                    <measurement group_id="O18" value="10.8" lower_limit="5.95" upper_limit="19.6"/>
                    <measurement group_id="O19" value="13" lower_limit="6.65" upper_limit="25.5"/>
                    <measurement group_id="O20" value="2.14" lower_limit="1.51" upper_limit="3.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of Adult Subjects With ≥Two-fold and ≥Four-fold Increase in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for O78 Antigen</title>
        <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second).</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of Adult Subjects With ≥Two-fold and ≥Four-fold Increase in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for O78 Antigen</title>
          <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second).</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>≥Two-fold</title>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>≥Four-fold</title>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Titer (GMT) for Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for O78 Antigen, Among Adults</title>
        <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second).</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Titer (GMT) for Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for O78 Antigen, Among Adults</title>
          <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second).</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="177" lower_limit="109" upper_limit="287"/>
                    <measurement group_id="O2" value="166" lower_limit="92.0" upper_limit="301"/>
                    <measurement group_id="O3" value="30.9" lower_limit="17.2" upper_limit="55.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Fold Change in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for O78 Antigen, Among Adults</title>
        <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second).</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Fold Change in Plasma Immunoglobulin A (IgA) Response After Either Vaccine Dose, for O78 Antigen, Among Adults</title>
          <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second).</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>fold change</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.15" lower_limit="2.27" upper_limit="4.37"/>
                    <measurement group_id="O2" value="4.66" lower_limit="2.21" upper_limit="9.84"/>
                    <measurement group_id="O3" value="0.976" lower_limit="0.609" upper_limit="1.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of Subjects With ≥Two-fold and ≥Four-fold Increase in Plasma Immunoglobulin G (IgG) Response to E. Coli Heat-labile Enterotoxin (LTB) After Either Vaccine Dose</title>
        <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). B-subunit of the E. coli heat-labile enterotoxin (LTB) was one of the antigens in the ETVAX vaccine.</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O10">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O15">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of Subjects With ≥Two-fold and ≥Four-fold Increase in Plasma Immunoglobulin G (IgG) Response to E. Coli Heat-labile Enterotoxin (LTB) After Either Vaccine Dose</title>
          <description>Between baseline and post-immunization (measured 7 days after the first dose and 5 days after the second). B-subunit of the E. coli heat-labile enterotoxin (LTB) was one of the antigens in the ETVAX vaccine.</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="49"/>
                <count group_id="O10" value="13"/>
                <count group_id="O11" value="15"/>
                <count group_id="O12" value="13"/>
                <count group_id="O13" value="13"/>
                <count group_id="O14" value="39"/>
                <count group_id="O15" value="30"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="26"/>
                <count group_id="O19" value="29"/>
                <count group_id="O20" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>≥Two-fold</title>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="15"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="8"/>
                    <measurement group_id="O11" value="8"/>
                    <measurement group_id="O12" value="13"/>
                    <measurement group_id="O13" value="13"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="19"/>
                    <measurement group_id="O16" value="24"/>
                    <measurement group_id="O17" value="21"/>
                    <measurement group_id="O18" value="19"/>
                    <measurement group_id="O19" value="23"/>
                    <measurement group_id="O20" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="44"/>
                    <measurement group_id="O10" value="5"/>
                    <measurement group_id="O11" value="7"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="38"/>
                    <measurement group_id="O15" value="11"/>
                    <measurement group_id="O16" value="6"/>
                    <measurement group_id="O17" value="4"/>
                    <measurement group_id="O18" value="7"/>
                    <measurement group_id="O19" value="6"/>
                    <measurement group_id="O20" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>≥Four-fold</title>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="9"/>
                    <measurement group_id="O8" value="8"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="6"/>
                    <measurement group_id="O13" value="10"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="14"/>
                    <measurement group_id="O16" value="15"/>
                    <measurement group_id="O17" value="16"/>
                    <measurement group_id="O18" value="12"/>
                    <measurement group_id="O19" value="13"/>
                    <measurement group_id="O20" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="6"/>
                    <measurement group_id="O8" value="7"/>
                    <measurement group_id="O9" value="47"/>
                    <measurement group_id="O10" value="10"/>
                    <measurement group_id="O11" value="12"/>
                    <measurement group_id="O12" value="7"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="39"/>
                    <measurement group_id="O15" value="16"/>
                    <measurement group_id="O16" value="15"/>
                    <measurement group_id="O17" value="9"/>
                    <measurement group_id="O18" value="14"/>
                    <measurement group_id="O19" value="16"/>
                    <measurement group_id="O20" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Titer (GMT) of Plasma Immunoglobulin G (IgG) Response to E. Coli Heat-labile Enterotoxin (LTB) After Either Vaccine Dose</title>
        <description>Measured 7 days after the first dose and 5 days after the second). B-subunit of the E. coli heat-labile enterotoxin (LTB) was one of the antigens in the ETVAX vaccine.</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O10">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O15">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Titer (GMT) of Plasma Immunoglobulin G (IgG) Response to E. Coli Heat-labile Enterotoxin (LTB) After Either Vaccine Dose</title>
          <description>Measured 7 days after the first dose and 5 days after the second). B-subunit of the E. coli heat-labile enterotoxin (LTB) was one of the antigens in the ETVAX vaccine.</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="49"/>
                <count group_id="O10" value="13"/>
                <count group_id="O11" value="15"/>
                <count group_id="O12" value="13"/>
                <count group_id="O13" value="13"/>
                <count group_id="O14" value="39"/>
                <count group_id="O15" value="30"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="26"/>
                <count group_id="O19" value="29"/>
                <count group_id="O20" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1582" lower_limit="989" upper_limit="2530"/>
                    <measurement group_id="O2" value="1125" lower_limit="589" upper_limit="2148"/>
                    <measurement group_id="O3" value="85.1" lower_limit="41.2" upper_limit="176"/>
                    <measurement group_id="O4" value="5700" lower_limit="3337" upper_limit="9736"/>
                    <measurement group_id="O5" value="5047" lower_limit="2475" upper_limit="10291"/>
                    <measurement group_id="O6" value="3784" lower_limit="2074" upper_limit="6902"/>
                    <measurement group_id="O7" value="3006" lower_limit="1708" upper_limit="5290"/>
                    <measurement group_id="O8" value="2470" lower_limit="1459" upper_limit="4179"/>
                    <measurement group_id="O9" value="721" lower_limit="575" upper_limit="904"/>
                    <measurement group_id="O10" value="3644" lower_limit="1798" upper_limit="7387"/>
                    <measurement group_id="O11" value="2401" lower_limit="1539" upper_limit="3746"/>
                    <measurement group_id="O12" value="1565" lower_limit="1060" upper_limit="2312"/>
                    <measurement group_id="O13" value="5163" lower_limit="3144" upper_limit="8478"/>
                    <measurement group_id="O14" value="788" lower_limit="636" upper_limit="976"/>
                    <measurement group_id="O15" value="1314" lower_limit="747" upper_limit="2311"/>
                    <measurement group_id="O16" value="3561" lower_limit="2062" upper_limit="6149"/>
                    <measurement group_id="O17" value="3935" lower_limit="2522" upper_limit="6141"/>
                    <measurement group_id="O18" value="1488" lower_limit="710" upper_limit="3120"/>
                    <measurement group_id="O19" value="1521" lower_limit="779" upper_limit="2970"/>
                    <measurement group_id="O20" value="513" lower_limit="341" upper_limit="772"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Fold Change of Plasma Immunoglobulin G (IgG) Response to E. Coli Heat-labile Enterotoxin (LTB) After Either Vaccine Dose</title>
        <description>Between baseline and after vaccination (measured 7 days after the first dose and 5 days after the second). B-subunit of the E. coli heat-labile enterotoxin (LTB) was one of the antigens in the ETVAX vaccine.</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O10">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O15">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Fold Change of Plasma Immunoglobulin G (IgG) Response to E. Coli Heat-labile Enterotoxin (LTB) After Either Vaccine Dose</title>
          <description>Between baseline and after vaccination (measured 7 days after the first dose and 5 days after the second). B-subunit of the E. coli heat-labile enterotoxin (LTB) was one of the antigens in the ETVAX vaccine.</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>fold change</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="49"/>
                <count group_id="O10" value="13"/>
                <count group_id="O11" value="15"/>
                <count group_id="O12" value="13"/>
                <count group_id="O13" value="13"/>
                <count group_id="O14" value="39"/>
                <count group_id="O15" value="30"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="26"/>
                <count group_id="O19" value="29"/>
                <count group_id="O20" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.53" lower_limit="3.92" upper_limit="10.9"/>
                    <measurement group_id="O2" value="10.3" lower_limit="5.69" upper_limit="18.6"/>
                    <measurement group_id="O3" value="1.11" lower_limit="0.807" upper_limit="1.53"/>
                    <measurement group_id="O4" value="3.53" lower_limit="2.26" upper_limit="5.49"/>
                    <measurement group_id="O5" value="7.57" lower_limit="4.47" upper_limit="12.8"/>
                    <measurement group_id="O6" value="6.39" lower_limit="3.83" upper_limit="10.7"/>
                    <measurement group_id="O7" value="5.02" lower_limit="3.16" upper_limit="7.98"/>
                    <measurement group_id="O8" value="4.69" lower_limit="3.16" upper_limit="7.98"/>
                    <measurement group_id="O9" value="1.23" lower_limit="1.05" upper_limit="1.43"/>
                    <measurement group_id="O10" value="3.56" lower_limit="1.60" upper_limit="7.91"/>
                    <measurement group_id="O11" value="2.21" lower_limit="1.63" upper_limit="3.01"/>
                    <measurement group_id="O12" value="4.73" lower_limit="3.18" upper_limit="7.04"/>
                    <measurement group_id="O13" value="8.77" lower_limit="5.35" upper_limit="14.4"/>
                    <measurement group_id="O14" value="0.996" lower_limit="0.893" upper_limit="1.11"/>
                    <measurement group_id="O15" value="4.3" lower_limit="2.71" upper_limit="6.81"/>
                    <measurement group_id="O16" value="5.64" lower_limit="3.52" upper_limit="9.04"/>
                    <measurement group_id="O17" value="5.47" lower_limit="3.42" upper_limit="8.73"/>
                    <measurement group_id="O18" value="5.19" lower_limit="2.97" upper_limit="9.05"/>
                    <measurement group_id="O19" value="5.67" lower_limit="3.29" upper_limit="9.77"/>
                    <measurement group_id="O20" value="1.74" lower_limit="1.37" upper_limit="2.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Antigen Responses in Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Experienced by Subjects</title>
        <time_frame>19 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O10">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O15">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Antigen Responses in Antibody Lymphocyte Supernatant (ALS) Immunoglobulin A (IgA) Experienced by Subjects</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="49"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="15"/>
                <count group_id="O10" value="37"/>
                <count group_id="O11" value="12"/>
                <count group_id="O12" value="15"/>
                <count group_id="O13" value="13"/>
                <count group_id="O14" value="13"/>
                <count group_id="O15" value="49"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="30"/>
                <count group_id="O18" value="24"/>
                <count group_id="O19" value="26"/>
                <count group_id="O20" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>≥Two-fold</title>
              <category_list>
                <category>
                  <title>5 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="10"/>
                    <measurement group_id="O9" value="7"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="5"/>
                    <measurement group_id="O12" value="4"/>
                    <measurement group_id="O13" value="5"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="2"/>
                    <measurement group_id="O18" value="1"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>4 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="3"/>
                    <measurement group_id="O13" value="2"/>
                    <measurement group_id="O14" value="6"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="5"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="3"/>
                    <measurement group_id="O19" value="2"/>
                    <measurement group_id="O20" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="5"/>
                    <measurement group_id="O13" value="4"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="5"/>
                    <measurement group_id="O17" value="7"/>
                    <measurement group_id="O18" value="5"/>
                    <measurement group_id="O19" value="7"/>
                    <measurement group_id="O20" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="2"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="7"/>
                    <measurement group_id="O16" value="7"/>
                    <measurement group_id="O17" value="8"/>
                    <measurement group_id="O18" value="10"/>
                    <measurement group_id="O19" value="4"/>
                    <measurement group_id="O20" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 antigen</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="5"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="2"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="18"/>
                    <measurement group_id="O16" value="4"/>
                    <measurement group_id="O17" value="10"/>
                    <measurement group_id="O18" value="3"/>
                    <measurement group_id="O19" value="9"/>
                    <measurement group_id="O20" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>0 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="37"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="26"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="22"/>
                    <measurement group_id="O16" value="7"/>
                    <measurement group_id="O17" value="3"/>
                    <measurement group_id="O18" value="2"/>
                    <measurement group_id="O19" value="4"/>
                    <measurement group_id="O20" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>≥Four-fold</title>
              <category_list>
                <category>
                  <title>5 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="10"/>
                    <measurement group_id="O8" value="5"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="3"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>4 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="6"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="3"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="1"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="4"/>
                    <measurement group_id="O13" value="4"/>
                    <measurement group_id="O14" value="5"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="6"/>
                    <measurement group_id="O17" value="3"/>
                    <measurement group_id="O18" value="5"/>
                    <measurement group_id="O19" value="5"/>
                    <measurement group_id="O20" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="3"/>
                    <measurement group_id="O13" value="2"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="2"/>
                    <measurement group_id="O16" value="4"/>
                    <measurement group_id="O17" value="4"/>
                    <measurement group_id="O18" value="6"/>
                    <measurement group_id="O19" value="5"/>
                    <measurement group_id="O20" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 antigen</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="2"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="13"/>
                    <measurement group_id="O16" value="6"/>
                    <measurement group_id="O17" value="16"/>
                    <measurement group_id="O18" value="10"/>
                    <measurement group_id="O19" value="9"/>
                    <measurement group_id="O20" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>0 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="41"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="30"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="33"/>
                    <measurement group_id="O16" value="11"/>
                    <measurement group_id="O17" value="6"/>
                    <measurement group_id="O18" value="3"/>
                    <measurement group_id="O19" value="7"/>
                    <measurement group_id="O20" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Antigen Responses in Plasma Immunoglobulin A (IgA) Experienced by Subjects</title>
        <time_frame>19 days</time_frame>
        <population>Participants with results for all antigens (CFA/I, CS3, CS5, CS6, LTB) tested for.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult: Placebo</title>
            <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O2">
            <title>Adult: ETVAX (Full)</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
            <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>24-59 Months: Placebo</title>
            <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O5">
            <title>24-59 Months: ETVAX (1/4)</title>
            <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>24-59 Months: ETVAX (1/2)</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O7">
            <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O8">
            <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O9">
            <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
            <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O10">
            <title>12-23 Months: Placebo</title>
            <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O11">
            <title>12-23 Months: ETVAX (1/4)</title>
            <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O12">
            <title>12-23 Months: ETVAX (1/2)</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O13">
            <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O14">
            <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
            <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O15">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
          <group group_id="O16">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O17">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O18">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O19">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O20">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Antigen Responses in Plasma Immunoglobulin A (IgA) Experienced by Subjects</title>
          <population>Participants with results for all antigens (CFA/I, CS3, CS5, CS6, LTB) tested for.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="49"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
                <count group_id="O7" value="15"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="15"/>
                <count group_id="O10" value="39"/>
                <count group_id="O11" value="13"/>
                <count group_id="O12" value="15"/>
                <count group_id="O13" value="13"/>
                <count group_id="O14" value="13"/>
                <count group_id="O15" value="49"/>
                <count group_id="O16" value="30"/>
                <count group_id="O17" value="30"/>
                <count group_id="O18" value="25"/>
                <count group_id="O19" value="26"/>
                <count group_id="O20" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>≥Two-fold</title>
              <category_list>
                <category>
                  <title>5 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="2"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="4"/>
                    <measurement group_id="O15" value="4"/>
                    <measurement group_id="O16" value="5"/>
                    <measurement group_id="O17" value="6"/>
                    <measurement group_id="O18" value="6"/>
                    <measurement group_id="O19" value="9"/>
                    <measurement group_id="O20" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>4 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="6"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="3"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="4"/>
                    <measurement group_id="O16" value="6"/>
                    <measurement group_id="O17" value="2"/>
                    <measurement group_id="O18" value="2"/>
                    <measurement group_id="O19" value="1"/>
                    <measurement group_id="O20" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="7"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="2"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="5"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="8"/>
                    <measurement group_id="O18" value="2"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="4"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="7"/>
                    <measurement group_id="O16" value="4"/>
                    <measurement group_id="O17" value="5"/>
                    <measurement group_id="O18" value="6"/>
                    <measurement group_id="O19" value="8"/>
                    <measurement group_id="O20" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 antigen</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="9"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="3"/>
                    <measurement group_id="O13" value="4"/>
                    <measurement group_id="O14" value="4"/>
                    <measurement group_id="O15" value="9"/>
                    <measurement group_id="O16" value="7"/>
                    <measurement group_id="O17" value="7"/>
                    <measurement group_id="O18" value="8"/>
                    <measurement group_id="O19" value="4"/>
                    <measurement group_id="O20" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>0 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="36"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="22"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="20"/>
                    <measurement group_id="O16" value="6"/>
                    <measurement group_id="O17" value="2"/>
                    <measurement group_id="O18" value="1"/>
                    <measurement group_id="O19" value="4"/>
                    <measurement group_id="O20" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>≥Four-fold</title>
              <category_list>
                <category>
                  <title>5 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="1"/>
                    <measurement group_id="O18" value="2"/>
                    <measurement group_id="O19" value="3"/>
                    <measurement group_id="O20" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>4 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="2"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="2"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="2"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="1"/>
                    <measurement group_id="O20" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="2"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="5"/>
                    <measurement group_id="O18" value="2"/>
                    <measurement group_id="O19" value="4"/>
                    <measurement group_id="O20" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="5"/>
                    <measurement group_id="O9" value="6"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="2"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="5"/>
                    <measurement group_id="O16" value="5"/>
                    <measurement group_id="O17" value="7"/>
                    <measurement group_id="O18" value="5"/>
                    <measurement group_id="O19" value="5"/>
                    <measurement group_id="O20" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 antigen</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="5"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="7"/>
                    <measurement group_id="O13" value="5"/>
                    <measurement group_id="O14" value="7"/>
                    <measurement group_id="O15" value="11"/>
                    <measurement group_id="O16" value="11"/>
                    <measurement group_id="O17" value="8"/>
                    <measurement group_id="O18" value="13"/>
                    <measurement group_id="O19" value="5"/>
                    <measurement group_id="O20" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>0 antigens</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="43"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="31"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="3"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="28"/>
                    <measurement group_id="O16" value="9"/>
                    <measurement group_id="O17" value="7"/>
                    <measurement group_id="O18" value="3"/>
                    <measurement group_id="O19" value="8"/>
                    <measurement group_id="O20" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of 6-11 Month Old Subjects With ≥Two-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 7, by Antigen</title>
        <description>Fecal secretion was measured on Day 0 and Day 7 (7 days after administration of first dose of vaccine). Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>7 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of 6-11 Month Old Subjects With ≥Two-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 7, by Antigen</title>
          <description>Fecal secretion was measured on Day 0 and Day 7 (7 days after administration of first dose of vaccine). Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="16"/>
                    <count group_id="O5" value="13"/>
                    <count group_id="O6" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="17"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="16"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="16"/>
                    <count group_id="O5" value="17"/>
                    <count group_id="O6" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="17"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of 6-11 Month Old Subjects With ≥Four-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 7, by Antigen</title>
        <description>Fecal secretion was measured on Day 0 and Day 7 (7 days after administration of first dose of vaccine). Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>7 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of 6-11 Month Old Subjects With ≥Four-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 7, by Antigen</title>
          <description>Fecal secretion was measured on Day 0 and Day 7 (7 days after administration of first dose of vaccine). Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="16"/>
                    <count group_id="O5" value="13"/>
                    <count group_id="O6" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="17"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="16"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="16"/>
                    <count group_id="O5" value="17"/>
                    <count group_id="O6" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="17"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Titer (GMT) of Fecal Secretory Immunoglobulin A (SIgA) Response 6-11 Month Old Subjects on Day 7, by Antigen</title>
        <description>Fecal secretion was measured on Day 7 (7 days after administration of first dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>7 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Titer (GMT) of Fecal Secretory Immunoglobulin A (SIgA) Response 6-11 Month Old Subjects on Day 7, by Antigen</title>
          <description>Fecal secretion was measured on Day 7 (7 days after administration of first dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="16"/>
                    <count group_id="O5" value="13"/>
                    <count group_id="O6" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.6" lower_limit="20.2" upper_limit="122"/>
                    <measurement group_id="O2" value="94.7" lower_limit="35.7" upper_limit="251"/>
                    <measurement group_id="O3" value="53.8" lower_limit="19.3" upper_limit="150"/>
                    <measurement group_id="O4" value="125" lower_limit="59.8" upper_limit="260"/>
                    <measurement group_id="O5" value="70.6" lower_limit="42.1" upper_limit="118"/>
                    <measurement group_id="O6" value="57.1" lower_limit="28.7" upper_limit="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="17"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="111" lower_limit="45.4" upper_limit="270"/>
                    <measurement group_id="O2" value="94.7" lower_limit="35.7" upper_limit="251"/>
                    <measurement group_id="O3" value="53.8" lower_limit="19.3" upper_limit="150"/>
                    <measurement group_id="O4" value="125" lower_limit="59.8" upper_limit="260"/>
                    <measurement group_id="O5" value="70.6" lower_limit="42.1" upper_limit="118"/>
                    <measurement group_id="O6" value="57.1" lower_limit="28.7" upper_limit="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="16"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.8" lower_limit="15.8" upper_limit="48.8"/>
                    <measurement group_id="O2" value="65" lower_limit="30.9" upper_limit="137"/>
                    <measurement group_id="O3" value="19.5" lower_limit="10.1" upper_limit="37.8"/>
                    <measurement group_id="O4" value="60.7" lower_limit="37.1" upper_limit="99.3"/>
                    <measurement group_id="O5" value="59.8" lower_limit="32.3" upper_limit="111"/>
                    <measurement group_id="O6" value="35.6" lower_limit="22.3" upper_limit="56.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="17"/>
                    <count group_id="O6" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72" lower_limit="39.7" upper_limit="130"/>
                    <measurement group_id="O2" value="80.7" lower_limit="38.7" upper_limit="168"/>
                    <measurement group_id="O3" value="36.3" lower_limit="20.1" upper_limit="65.6"/>
                    <measurement group_id="O4" value="187" lower_limit="84.0" upper_limit="415"/>
                    <measurement group_id="O5" value="101" lower_limit="62.7" upper_limit="164"/>
                    <measurement group_id="O6" value="101" lower_limit="51.1" upper_limit="198"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="281" lower_limit="154" upper_limit="511"/>
                    <measurement group_id="O2" value="474" lower_limit="129" upper_limit="1747"/>
                    <measurement group_id="O3" value="345" lower_limit="160" upper_limit="745"/>
                    <measurement group_id="O4" value="1249" lower_limit="471" upper_limit="3311"/>
                    <measurement group_id="O5" value="536" lower_limit="235" upper_limit="1219"/>
                    <measurement group_id="O6" value="448" lower_limit="264" upper_limit="762"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Fold Change of Fecal Secretory Immunoglobulin A (SIgA) Response Among 6-11 Month Old Subjects on Day 7, by Antigen</title>
        <description>Fecal secretion was measured on Day 0 and Day 7 (7 days after administration of first dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>7 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Fold Change of Fecal Secretory Immunoglobulin A (SIgA) Response Among 6-11 Month Old Subjects on Day 7, by Antigen</title>
          <description>Fecal secretion was measured on Day 0 and Day 7 (7 days after administration of first dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>fold change</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="16"/>
                    <count group_id="O5" value="13"/>
                    <count group_id="O6" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.05" lower_limit="1.16" upper_limit="3.63"/>
                    <measurement group_id="O2" value="0.98" lower_limit="0.447" upper_limit="2.15"/>
                    <measurement group_id="O3" value="1.12" lower_limit="0.418" upper_limit="3.02"/>
                    <measurement group_id="O4" value="2.92" lower_limit="1.24" upper_limit="6.88"/>
                    <measurement group_id="O5" value="1.53" lower_limit="0.708" upper_limit="3.29"/>
                    <measurement group_id="O6" value="1.07" lower_limit="0.456" upper_limit="2.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="17"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.32" lower_limit="0.715" upper_limit="2.42"/>
                    <measurement group_id="O2" value="0.587" lower_limit="0.373" upper_limit="0.925"/>
                    <measurement group_id="O3" value="0.884" lower_limit="0.401" upper_limit="1.95"/>
                    <measurement group_id="O4" value="2.71" lower_limit="1.11" upper_limit="6.64"/>
                    <measurement group_id="O5" value="1.73" lower_limit="0.975" upper_limit="3.07"/>
                    <measurement group_id="O6" value="0.989" lower_limit="0.613" upper_limit="1.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="16"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.37" lower_limit="0.900" upper_limit="2.09"/>
                    <measurement group_id="O2" value="0.981" lower_limit="0.594" upper_limit="1.62"/>
                    <measurement group_id="O3" value="1.19" lower_limit="0.496" upper_limit="2.85"/>
                    <measurement group_id="O4" value="2.22" lower_limit="1.16" upper_limit="4.26"/>
                    <measurement group_id="O5" value="0.793" lower_limit="0.383" upper_limit="1.64"/>
                    <measurement group_id="O6" value="0.841" lower_limit="0.478" upper_limit="1.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="16"/>
                    <count group_id="O5" value="17"/>
                    <count group_id="O6" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.09" lower_limit="0.471" upper_limit="2.51"/>
                    <measurement group_id="O2" value="0.718" lower_limit="0.424" upper_limit="1.22"/>
                    <measurement group_id="O3" value="0.529" lower_limit="0.126" upper_limit="2.23"/>
                    <measurement group_id="O4" value="3.75" lower_limit="1.51" upper_limit="9.32"/>
                    <measurement group_id="O5" value="1.02" lower_limit="0.617" upper_limit="1.70"/>
                    <measurement group_id="O6" value="1.09" lower_limit="0.479" upper_limit="2.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="17"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.63" lower_limit="0.718" upper_limit="3.68"/>
                    <measurement group_id="O2" value="0.937" lower_limit="0.523" upper_limit="1.68"/>
                    <measurement group_id="O3" value="1.76" lower_limit="0.941" upper_limit="3.30"/>
                    <measurement group_id="O4" value="2.54" lower_limit="1.06" upper_limit="6.09"/>
                    <measurement group_id="O5" value="2.01" lower_limit="0.745" upper_limit="5.40"/>
                    <measurement group_id="O6" value="1.1" lower_limit="0.601" upper_limit="2.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of 6-11 Month Old Subjects With ≥Two-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 19, by Antigen</title>
        <description>Fecal secretion was measured on Day 0 and Day 19 (5 days after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>Day 19</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of 6-11 Month Old Subjects With ≥Two-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 19, by Antigen</title>
          <description>Fecal secretion was measured on Day 0 and Day 19 (5 days after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of 6-11 Month Old Subjects With ≥Four-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 19, by Antigen</title>
        <description>Fecal secretion was measured on Day 0 and Day 19 (5 days after administration of second dose of vaccine). Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of 6-11 Month Old Subjects With ≥Four-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 19, by Antigen</title>
          <description>Fecal secretion was measured on Day 0 and Day 19 (5 days after administration of second dose of vaccine). Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Titer (GMT) of Fecal Secretory Immunoglobulin A (SIgA) Response 6-11 Month Old Subjects on Day 19, by Antigen</title>
        <description>Fecal secretion was measured on Day 19 (5 days after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Titer (GMT) of Fecal Secretory Immunoglobulin A (SIgA) Response 6-11 Month Old Subjects on Day 19, by Antigen</title>
          <description>Fecal secretion was measured on Day 19 (5 days after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.3" lower_limit="18.3" upper_limit="76.2"/>
                    <measurement group_id="O2" value="99.1" lower_limit="57.6" upper_limit="170"/>
                    <measurement group_id="O3" value="40.2" lower_limit="16.1" upper_limit="100"/>
                    <measurement group_id="O4" value="102" lower_limit="50.2" upper_limit="209"/>
                    <measurement group_id="O5" value="48.9" lower_limit="21.6" upper_limit="111"/>
                    <measurement group_id="O6" value="66.3" lower_limit="43.7" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107" lower_limit="47.8" upper_limit="240"/>
                    <measurement group_id="O2" value="158" lower_limit="75.3" upper_limit="330"/>
                    <measurement group_id="O3" value="48.7" lower_limit="17.1" upper_limit="139"/>
                    <measurement group_id="O4" value="136" lower_limit="74.6" upper_limit="246"/>
                    <measurement group_id="O5" value="166" lower_limit="94.9" upper_limit="292"/>
                    <measurement group_id="O6" value="118" lower_limit="83.1" upper_limit="166"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.8" lower_limit="16.4" upper_limit="47.1"/>
                    <measurement group_id="O2" value="72.7" lower_limit="40.1" upper_limit="132"/>
                    <measurement group_id="O3" value="22.1" lower_limit="7.04" upper_limit="69.6"/>
                    <measurement group_id="O4" value="50.5" lower_limit="34.3" upper_limit="74.3"/>
                    <measurement group_id="O5" value="63.5" lower_limit="27.7" upper_limit="146"/>
                    <measurement group_id="O6" value="45.8" lower_limit="33.0" upper_limit="63.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.2" lower_limit="33.2" upper_limit="117"/>
                    <measurement group_id="O2" value="135" lower_limit="68.4" upper_limit="268"/>
                    <measurement group_id="O3" value="29.8" lower_limit="11.5" upper_limit="77.7"/>
                    <measurement group_id="O4" value="121" lower_limit="57.8" upper_limit="252"/>
                    <measurement group_id="O5" value="94.8" lower_limit="60.0" upper_limit="150"/>
                    <measurement group_id="O6" value="110" lower_limit="71.7" upper_limit="170"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="306" lower_limit="171" upper_limit="549"/>
                    <measurement group_id="O2" value="1246" lower_limit="627" upper_limit="2475"/>
                    <measurement group_id="O3" value="587" lower_limit="202" upper_limit="1707"/>
                    <measurement group_id="O4" value="1507" lower_limit="639" upper_limit="3559"/>
                    <measurement group_id="O5" value="838" lower_limit="390" upper_limit="1802"/>
                    <measurement group_id="O6" value="533" lower_limit="317" upper_limit="897"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Fold Change of Fecal Secretory Immunoglobulin A (SIgA) Response Among 6-11 Month Old Subjects on Day 19, by Antigen</title>
        <description>Fecal secretion was measured on Day 0 and Day 19 (5 days after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>19 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Fold Change of Fecal Secretory Immunoglobulin A (SIgA) Response Among 6-11 Month Old Subjects on Day 19, by Antigen</title>
          <description>Fecal secretion was measured on Day 0 and Day 19 (5 days after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>fold change</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.81" lower_limit="1.12" upper_limit="2.91"/>
                    <measurement group_id="O2" value="1.18" lower_limit="0.627" upper_limit="2.23"/>
                    <measurement group_id="O3" value="0.975" lower_limit="0.292" upper_limit="3.25"/>
                    <measurement group_id="O4" value="2.31" lower_limit="1.16" upper_limit="4.59"/>
                    <measurement group_id="O5" value="1.08" lower_limit="0.366" upper_limit="3.18"/>
                    <measurement group_id="O6" value="1.23" lower_limit="0.780" upper_limit="1.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.36" lower_limit="0.946" upper_limit="1.94"/>
                    <measurement group_id="O2" value="1.19" lower_limit="0.641" upper_limit="2.22"/>
                    <measurement group_id="O3" value="0.97" lower_limit="0.310" upper_limit="3.04"/>
                    <measurement group_id="O4" value="1.88" lower_limit="0.923" upper_limit="3.84"/>
                    <measurement group_id="O5" value="1.52" lower_limit="0.820" upper_limit="2.80"/>
                    <measurement group_id="O6" value="1.1" lower_limit="0.754" upper_limit="1.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.44" lower_limit="0.848" upper_limit="2.44"/>
                    <measurement group_id="O2" value="1.24" lower_limit="0.599" upper_limit="2.58"/>
                    <measurement group_id="O3" value="1.37" lower_limit="0.423" upper_limit="4.44"/>
                    <measurement group_id="O4" value="1.92" lower_limit="0.991" upper_limit="3.71"/>
                    <measurement group_id="O5" value="0.888" lower_limit="0.408" upper_limit="1.93"/>
                    <measurement group_id="O6" value="1.1" lower_limit="0.710" upper_limit="1.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.896" lower_limit="0.529" upper_limit="1.52"/>
                    <measurement group_id="O2" value="1.42" lower_limit="0.655" upper_limit="3.07"/>
                    <measurement group_id="O3" value="0.457" lower_limit="0.109" upper_limit="1.92"/>
                    <measurement group_id="O4" value="2.41" lower_limit="1.09" upper_limit="5.32"/>
                    <measurement group_id="O5" value="0.96" lower_limit="0.533" upper_limit="1.73"/>
                    <measurement group_id="O6" value="1.2" lower_limit="0.739" upper_limit="1.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.75" lower_limit="0.809" upper_limit="3.77"/>
                    <measurement group_id="O2" value="1.99" lower_limit="0.987" upper_limit="4.00"/>
                    <measurement group_id="O3" value="3.25" lower_limit="1.03" upper_limit="10.2"/>
                    <measurement group_id="O4" value="3.19" lower_limit="1.52" upper_limit="6.69"/>
                    <measurement group_id="O5" value="3.64" lower_limit="1.45" upper_limit="9.12"/>
                    <measurement group_id="O6" value="1.64" lower_limit="0.904" upper_limit="2.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of 6-11 Month Old Subjects With ≥Two-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 28, by Antigen</title>
        <description>Fecal secretion was measured on Day 0 and Day 28 (2 weeks after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>28 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of 6-11 Month Old Subjects With ≥Two-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 28, by Antigen</title>
          <description>Fecal secretion was measured on Day 0 and Day 28 (2 weeks after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="18"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="18"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="18"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of 6-11 Month Old Subjects With ≥Four-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 28, by Antigen</title>
        <description>Fecal secretion was measured on Day 0 and Day 28 (2 weeks after administration of second dose of vaccine). Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>28 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of 6-11 Month Old Subjects With ≥Four-fold Increase in Fecal Secretory Immunoglobulin A (SIgA) Response on Day 28, by Antigen</title>
          <description>Fecal secretion was measured on Day 0 and Day 28 (2 weeks after administration of second dose of vaccine). Antigens in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="18"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="18"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="18"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Titer (GMT) of Fecal Secretory Immunoglobulin A (SIgA) Response 6-11 Month Old Subjects on Day 28, by Antigen</title>
        <description>Fecal secretion was measured on Day 28 (2 weeks after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>28 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Titer (GMT) of Fecal Secretory Immunoglobulin A (SIgA) Response 6-11 Month Old Subjects on Day 28, by Antigen</title>
          <description>Fecal secretion was measured on Day 28 (2 weeks after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="18"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.4" lower_limit="18.4" upper_limit="149"/>
                    <measurement group_id="O2" value="178" lower_limit="76.7" upper_limit="414"/>
                    <measurement group_id="O3" value="72.6" lower_limit="22.2" upper_limit="237"/>
                    <measurement group_id="O4" value="126" lower_limit="57.6" upper_limit="274"/>
                    <measurement group_id="O5" value="136" lower_limit="90.9" upper_limit="204"/>
                    <measurement group_id="O6" value="61.8" lower_limit="34.4" upper_limit="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106" lower_limit="40.1" upper_limit="281"/>
                    <measurement group_id="O2" value="271" lower_limit="105" upper_limit="699"/>
                    <measurement group_id="O3" value="57.5" lower_limit="32.6" upper_limit="101"/>
                    <measurement group_id="O4" value="223" lower_limit="120" upper_limit="413"/>
                    <measurement group_id="O5" value="373" lower_limit="158" upper_limit="877"/>
                    <measurement group_id="O6" value="181" lower_limit="121" upper_limit="273"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="18"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.8" lower_limit="15.4" upper_limit="281"/>
                    <measurement group_id="O2" value="271" lower_limit="105" upper_limit="699"/>
                    <measurement group_id="O3" value="57.5" lower_limit="32.6" upper_limit="101"/>
                    <measurement group_id="O4" value="223" lower_limit="120" upper_limit="413"/>
                    <measurement group_id="O5" value="373" lower_limit="158" upper_limit="877"/>
                    <measurement group_id="O6" value="181" lower_limit="121" upper_limit="273"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="18"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.8" lower_limit="29.0" upper_limit="115"/>
                    <measurement group_id="O2" value="145" lower_limit="72.2" upper_limit="293"/>
                    <measurement group_id="O3" value="44.2" lower_limit="13.0" upper_limit="150"/>
                    <measurement group_id="O4" value="138" lower_limit="71.8" upper_limit="266"/>
                    <measurement group_id="O5" value="163" lower_limit="55.3" upper_limit="484"/>
                    <measurement group_id="O6" value="86.1" lower_limit="45.8" upper_limit="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="517" lower_limit="264" upper_limit="1010"/>
                    <measurement group_id="O2" value="2151" lower_limit="875" upper_limit="5291"/>
                    <measurement group_id="O3" value="911" lower_limit="364" upper_limit="2277"/>
                    <measurement group_id="O4" value="2231" lower_limit="1018" upper_limit="4888"/>
                    <measurement group_id="O5" value="1128" lower_limit="376" upper_limit="3381"/>
                    <measurement group_id="O6" value="391" lower_limit="230" upper_limit="665"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Fold Change of Fecal Secretory Immunoglobulin A (SIgA) Response Among 6-11 Month Old Subjects on Day 28, by Antigen</title>
        <description>Fecal secretion was measured on Day 0 and Day 28 (2 weeks after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
        <time_frame>28 days</time_frame>
        <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
        <group_list>
          <group group_id="O1">
            <title>6-11 Months: ETVAX (1/8)</title>
            <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O2">
            <title>6-11 Months: ETVAX (1/4)</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O3">
            <title>6-11 Months: ETVAX (1/2)</title>
            <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O4">
            <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O5">
            <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
            <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
          </group>
          <group group_id="O6">
            <title>6-11 Month Olds: Placebo</title>
            <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Fold Change of Fecal Secretory Immunoglobulin A (SIgA) Response Among 6-11 Month Old Subjects on Day 28, by Antigen</title>
          <description>Fecal secretion was measured on Day 0 and Day 28 (2 weeks after administration of second dose of vaccine). Antigen in ETVAX were:
E. coli, CFA/I, strain ETEX 21 formalin inactivated, E. coli, CS3, strain ETEX 22 formalin inactivated, E. coli, CS5, strain ETEX 23 formalin inactivated, E. coli, CS6, strain ETEX 24 phenol inactivated, B-subunit of the E. coli heat-labile enterotoxin</description>
          <population>Subjects who received both vaccinations and had valid baseline and endline immunologic samples.</population>
          <units>fold change</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CFA/I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="18"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.74" lower_limit="1.16" upper_limit="6.47"/>
                    <measurement group_id="O2" value="2.35" lower_limit="0.930" upper_limit="5.92"/>
                    <measurement group_id="O3" value="1.46" lower_limit="0.380" upper_limit="5.92"/>
                    <measurement group_id="O4" value="2.73" lower_limit="1.18" upper_limit="6.34"/>
                    <measurement group_id="O5" value="2.35" lower_limit="0.941" upper_limit="5.88"/>
                    <measurement group_id="O6" value="1.32" lower_limit="0.767" upper_limit="2.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.28" lower_limit="0.512" upper_limit="3.20"/>
                    <measurement group_id="O2" value="1.59" lower_limit="0.528" upper_limit="4.81"/>
                    <measurement group_id="O3" value="1.02" lower_limit="0.408" upper_limit="2.55"/>
                    <measurement group_id="O4" value="2.83" lower_limit="1.33" upper_limit="6.04"/>
                    <measurement group_id="O5" value="3.08" lower_limit="1.69" upper_limit="5.61"/>
                    <measurement group_id="O6" value="1.71" lower_limit="1.02" upper_limit="2.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="18"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.63" lower_limit="0.857" upper_limit="3.10"/>
                    <measurement group_id="O2" value="1.61" lower_limit="0.757" upper_limit="3.42"/>
                    <measurement group_id="O3" value="1.42" lower_limit="0.410" upper_limit="4.91"/>
                    <measurement group_id="O4" value="1.85" lower_limit="0.929" upper_limit="3.70"/>
                    <measurement group_id="O5" value="1.18" lower_limit="0.484" upper_limit="2.87"/>
                    <measurement group_id="O6" value="1.16" lower_limit="0.618" upper_limit="2.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="18"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.882" lower_limit="0.401" upper_limit="1.94"/>
                    <measurement group_id="O2" value="1.5" lower_limit="0.723" upper_limit="3.10"/>
                    <measurement group_id="O3" value="0.709" lower_limit="0.180" upper_limit="2.80"/>
                    <measurement group_id="O4" value="2.6" lower_limit="1.32" upper_limit="5.15"/>
                    <measurement group_id="O5" value="1.39" lower_limit="0.593" upper_limit="3.24"/>
                    <measurement group_id="O6" value="1.05" lower_limit="0.575" upper_limit="1.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LTB</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="16"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="19"/>
                    <count group_id="O6" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.14" lower_limit="0.763" upper_limit="6.01"/>
                    <measurement group_id="O2" value="1.92" lower_limit="0.755" upper_limit="4.90"/>
                    <measurement group_id="O3" value="4.58" lower_limit="1.79" upper_limit="11.7"/>
                    <measurement group_id="O4" value="5.33" lower_limit="2.01" upper_limit="14.2"/>
                    <measurement group_id="O5" value="4.65" lower_limit="1.41" upper_limit="15.3"/>
                    <measurement group_id="O6" value="1.19" lower_limit="0.612" upper_limit="2.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months ± 14 days after the first dose for unsolicited adverse events, 7 days for solicited events (fever, vomiting, loose stools, diarrhea, acute systemic allergic reaction; plus nausea and abdominal pain/stomach ache for adults/children 24-59 months)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Adult: ETVAX (Full)</title>
          <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E2">
          <title>Adult: ETVAX (Full) + 10 ug dmLT</title>
          <description>Adult arm (18-45 year olds) receiving the full dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) with 10 ug dmLT added to bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E3">
          <title>Adult: Placebo</title>
          <description>Adult arm (18-45 year olds) receiving a placebo on days 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
        </group>
        <group group_id="E4">
          <title>24-59 Months: ETVAX (1/4)</title>
          <description>24-59 month old children receiving a quarter adult dose (2.5 x 10^10 inactivated E. coli bacteria) of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E5">
          <title>24-59 Months: ETVAX (1/2)</title>
          <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E6">
          <title>24-59 Months: ETVAX (Full)</title>
          <description>24-59 month old children receiving a full adult dose of ETVAX vaccine (10^11 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E7">
          <title>24-59 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
          <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E8">
          <title>24-59 Months: ETVAX (1/2) + 5 ug dmLT</title>
          <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E9">
          <title>24-59 Months: ETVAX (1/2) + 10 ug dmLT</title>
          <description>24-59 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 10 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E10">
          <title>24-59 Months: Placebo</title>
          <description>24-59 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
        </group>
        <group group_id="E11">
          <title>12-23 Months: ETVAX (1/4)</title>
          <description>12-23 month old children receiving a quarter adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E12">
          <title>12-23 Months: ETVAX (1/2)</title>
          <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E13">
          <title>12-23 Months: ETVAX (1/2) + 2.5 ug dmLT</title>
          <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E14">
          <title>12-23 Months: ETVAX (1/2) + 5 ug dmLT</title>
          <description>12-23 month old children receiving a half adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E15">
          <title>12-23 Months: Placebo</title>
          <description>12-23 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
        </group>
        <group group_id="E16">
          <title>6-11 Months: ETVAX (1/8)</title>
          <description>6-11 month old children receiving an eighth of an adult dose of ETVAX vaccine in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E17">
          <title>6-11 Months: ETVAX (1/4)</title>
          <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E18">
          <title>6-11 Months: ETVAX (1/2)</title>
          <description>6-11 month old children receiving a half of an adult dose of ETVAX vaccine (5 x 10^10 inactivated E. coli bacteria) in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E19">
          <title>6-11 Months: ETVAX (1/4) + 2.5 ug dmLT</title>
          <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 2.5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E20">
          <title>6-11 Month Olds: ETVAX (1/4) + 5 ug dmLT</title>
          <description>6-11 month old children receiving a quarter of an adult dose of ETVAX vaccine (2.5 x 10^10 inactivated E. coli bacteria) plus 5 ug dmLT in bicarbonate buffer solution administered orally on Day 0 and 14</description>
        </group>
        <group group_id="E21">
          <title>6-11 Month Olds: Placebo</title>
          <description>6-11 month old children receiving a placebo of bicarbonate buffer solution administered orally on Day 0 and 14
Bicarbonate Buffer: Sodium bicarbonate buffer dissolved in 150 ml of potable water</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (Unspecified)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rickets</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (Unspecified)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="9" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="5" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="4" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="8" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="13" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="9" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="8" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="10" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Keratitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Loose stools</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="3" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="3" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="6" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="8" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="5" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="8" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="6" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="5" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="2" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchiolitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Measles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Varicella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Foreign body in eye</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dandruff</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jorge Flores</name_or_title>
      <organization>PATH</organization>
      <phone>(202) 822-0033</phone>
      <email>jeflores@path.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

